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ABSTRACT

This study further characterized a newly discovered interaction of two nutrients,
choline and carnitine. Increased dietary choline had previously been demonstrated to
cause a conservation of carnitine in humans and guinea pigs, and an increased muscle
carnitine concentration guinea pigs. The first part of this study compared the effect of
varied doses of choline on urinary excretion of carnitine, tissue and whole body
carnitine concentrations, and body composition. It was demonstrated that a choline
dose of 2 g/kg diet results in a near maximal effect on urinary conservation of
carnitine, which is mediated by an increase in the fractional tubular reabsorption of
carnitine. There was also a dose dependent decrease in the ratio of fat/protein of
carcasses of choline supplemented animals. The second part of the study evaluated
functional consequences of the choline-carnitine interaction. Indirect calorimetry was
used to evaluate energy substrate utilization in choline supplemented (3 g/kg diet) and
nonsupplemented guinea pigs. There was no effect of choline supplementation on
fatty acid oxidation in the guinea pigs when fed, unfed, or during treadmill exercise.
The mechanism of how choline supplementation affects body fat composition in
guinea pigs remains unknown, but appears to be independent of effects on capacity
for fatty acid oxidation.
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Chapter 1
Introduction
Two molecules are of primary importance in the research presented here: choline,
and carnitine. Choline and carnitine are both common constituents of most diets, but
carnitine is not an essential nutrient and choline is not universally recognized as
essential (Rebouche 1986 and Zeise] et al. 1991).
We have previously shown that choline supplementation, results in a substantial
decrease in the urinary excretion of carnitine in humans (Daily and Sachan 1995,
Dodson and Sachan 1996). The decreased excretion of carnitine was accompanied by
variable changes in plasma carnitine concentrations, and it was concluded that there
was no significant effect on plasma carnitine concentrations. In rats, carnitine
excretion was unaffected by choline both in our studies and those of others (Daily and
Sachan 1995, Sheard et al. 1992). Guinea pigs, however, did exhibit a pattern of
carnitine excretion similar to that of humans during choline supplementation, but had
an increased plasma carnitine concentration, unlike humans. We have attributed the
lack of effect in rats to the high choline oxidase activity in rat liver, 60 fold higher
than that in humans and 20 fold higher than that guinea pigs (Sidransky & Farber
1960).
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There are several possible explanations for the decreased excretion of carnitine
during choline supplementation. Absorption of dietary carnitine could be impaired and
less carnitine available to be excreted. The guinea pig diet, however, did not have
enough carnitine to be detectable and should not have been able to contribute enough
carnitine to be significant. Choline may have impaired the biosynthesis of carnitine,
but that seems unlikely because choline deficiency results in a carnitine deficiency
(Carter & Frenkel 1978) and excess has not been shown to impair synthesis. Another
likely explanation is that carnitine is being redistributed among body pools with some
tissues taking up carnitine. If this were the case, it might indicate an i�creased need
for carnitine in the affected tissues and be an indicator of increased fatty acid
oxidation or at least an increased capacity for fatty acid oxidation.
Choline and carnitine are all sold as supplements in the United States. Any
interaction between them that might affect the status of the other would have
significant implications. We have demonstrated that choline does affect carnitine
homeostasis. In guinea pigs this has been demonstrated at a level of 3 g/kg diet of
supplemental choline. The first study presented here is a dose response study to
determine what levels of supplementation are required for a maximal effect of choline
on urinary carnitine excretion and carnitine concentrations in guinea pig plasma and
tissues. Because of the obligatory role of carnitine in the oxidation of fatty acids, the
second study investigates the physiological consequences of choline supplementation
on fat metabolism in guinea pigs.
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Chapter 2
Literature Review
Choline

Choline is a quaternary trimethylated amine as is carnitine, another nutrient of
primary importance in this research. Choline is synthesized de novo in humans, but is
also widely available in the diet. Choline deficiency has been induced in animals
resulting in liver damage, renal hemorrhage, and inability to export triglyceride from
the liver, thereby causing hepatic fat accumulation (Kuksis & Mookerjea 1984). There
has never been a case of choline deficiency syndrome observed in humans, probably
because of its ubiquitous nature in the human diet.

Choline in the diet:

Daily dietary intake of choline is estimated at between 600 and 900 mg/day
(Kuksis A. & Mookerjea 1984). Choline is available from dietary sources both as
choline chloride and as phosphatidylcholine (lecithin). The best dietary sources of
choline include meat, eggs, oatmeal, soybeans, wheat germ, peanuts, and other nuts
and grains (Zeisel 1981). The most abundant form of choline in the diet is lecithin, but
many foods contain significant amounts of choline chloride, especially liver and
soybeans. Choline is also obtained in the diet from sources other than naturally
3

occurring foods. Lecithin is a common food additive because of its ability to emulsify
fats. It is a major ingredient in frying pan sprays, and is available as a nutritional
supplement as either lecithin or choline chloride.

Non dietary sources of choline:
Lecithin is formed in mammals by three different pathways; the base exchange
pathway, CDP-choline pathway, and the methyltransferase pathway (Zeisel 1981).
The base exchange pathway simply exchanges choline for another base on a
phospholipid. The CDP-choline pathway uses diacylglycerol and pre-existing choline
to form phosphatidylcholine. The methyltransferase pathway is the only way that new
choline is produced. In the methyltransferase pathway phosphatidylethanolamine is
sequentially methylated by phosphatidylethanolamine-N-methyltransferase (PEMT)
using S-adenosyl methionine (SAM) as the methyl source (Bjoranstad P. & Bremer J.
1966 and Lindblad L. & Schersten T. 1976). PEMT is most concentrated in the liver
but is also found in the kidney, testes, heart, lung, adrenal gland, erythrocytes, spleen,
and brain (Blusztajn J.K. et al. 1979, Hirata & Axelrod 1978, and Hirata et al. 1978).
In the rat about 15% of the choline requirement is supplied by the methyltransferase
pathway, and the remainder obtained from the diet (Zeise} 1981, Scheneider & Vance
1979, and Wise & Eleyn 1965). Human requirements for dietary choline, if any, are
not yet determined.
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Choline in single carbon metabolism:
Choline is frequently referred to as an important source of labile methyl groups
(Zeisel & Da Costa 1991). SAM is the active agent in many synthesis reactions
requiring the addition of a methyl group. When SAM donates it methyl group it is
hydrolyzed to form homocysteine and adenosine. The methionine may be regenerated
by the transfer of a methyl group from either N5- methyl tetrahydrofolate or betaine.
Both sources are of about equal importance in the rat (Finkelstein & Martin 1984).
Choline supplementation in rats has been shown to prevent pathology of folate
deficiency for up to three months (Aarsaether et al. 1988). Although choline is a
significant contributor of methyl groups in rats, its significance in humans is
questionable. The only way for choline to be used as a methyl source is for it to first
be oxidized to betaine. Human liver has only 1/60 of the choline oxidase activity of rat
liver (microliters of 02 uptake/brig wet liver) (Sidransky & Farber 1960). All studies
of choline as a methyl donor have used rats as an animal model and may not apply to
humans. However, even if humans do not utilize choline as a methyl donor, there are
other critical functions for choline in humans.

Functions of choline in humans:
The central nervous system requires choline for the synthesis of the important
neurotransmitter, acetylcholine. Acetylcholine is important for communication
between neurons in the central nervous system (CNS) and is also the neurotransmitter
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used for communication between the CNS and somatic motor neurons. Acetylcholine
is synthesized by the transfer of an acetyl group from acetyl coenzyme-A (CoA) to
choline in a reaction catalyzed by the enzyme choline acetyltransferase. Enzyme
kinetic studies of choline acetyltransferase in brain tissue suggest that the enzyme is
unlikely to ever be saturated, and that the rate of acetylcholine synthesis is controlled
by the availability of choline and/or acetyl CoA (White and Wu 1973). It has been
demonstrated that administration of choline simultaneously with an inducer of
cholinergic activity (3, 4-diaminopyridine) increases the synthesis and release of
acetylcholine in rats and that the two act synergistically for the greatest effect
(Buyukuysal, R.L. et. al. 1995).
Choline, as phosphatidylcholine and sphingomyelin, is a major structural
component of cell membranes. Phosphatidylcholine accounts for approximately 50%
of all cell membrane phospholipids and sphingomyelin 5-20% depending on the cell
type (Zeisel 1993).
Phosphatidylcholine is an important source of diacylglycerol used in maintaining
active protein kinase C within cells. The activation of protein kinase C is mediated by
binding to calcium and diacylglycerol in most isotypes, but some require only
diacylglycerol (Nishizuka 1992 and Exton 1990). Choline is also a part of the
membrane phospholipid, spingomyelin, which is involved in intracellular signaling.
Sphingomyelin is hydrolyzed to form ceramide and choline phosphate in response to
several known factors including l-a,25-dihydroxyvitamin D, tumor necrosis factor,
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and y-interferon (Merril 1992). Ceramide is a potent inhibitor of cell growth and
sphingosine an inhibitor of protein kinase C (Merril & Stevens 1989 and Merril &
Jones 1990). Choline itself has not yet been reported to be a signal transduction
molecule and its function, if any, when choline containing phospholipids are
hydrolyzed, is unknown.

Choline, an essential nutrient:
Choline has been shown to be an essential nutrient in many species including rat,
hamster, guinea pig, pig, dog, monkey, trout, and chicken (Finkelstein et al. 1982).
Choline deficiency results in spontaneous liver cancer in rats without exposure to
known carcinogens and is the only nutrient whose deficiency is known to result in
spontaneous malignancies (Newbeme & Roger 1990, and Zeisel 1993 ). Choline
deficiency, in species for which it has been shown to be essential, can result in
impaired hepatic, renal, and pancreatic function; memory loss, and decreased growth
(Finkelstein et al. 1982). It has been difficult to demonstrate that choline is an
essential nutrient for humans; however, it has been shown that human cells grown in
culture have an absolute requirement for choline (Eagle 1955). Malnourished humans
have decreased serum choline concentrations and parenterally fed persons without
choline supplementation develop abnormal liver function, indicating that there may be
a requirement for choline in the diet {Tayek et. al. 1990).
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Zeisel et al. (1991) conducted a human study in which the experimental group
received an artificial diet free of choline and a control group which received an
identical diet, except with added choline. They found decreased choline and
phosphatidylcholine in the plasma as expected, but also, the serum alanine
aminotransferase activity increased consistently over the three weeks in the choline
deficient group, and the study was terminated to avoid risk to the subjects.
A common problem among patients on long-term total parental nutrition (TPN) is
hepatic steatosis accompanied by lower than normal plasma choline concentrations
(Buchman et. al. 1992, Buchman et. al. 1 993). A study of 4 patients receiving long
term TPN (9. 7 ± 4.7 years) who had low plasma choline concentrations as well as
hepatic steatosis, evaluated choline supplementation as a treatment for the steatosis
(Buchman et. al. 1995). The degree of hepatic steatosis was determined by the use of
abdominal computed tomography (CT) before beginning the choline supplementation,
and after 2 and 6 weeks of supplementation. Liver density, in Hounsfeld units (HU)
can be used to estimate the degree of steatosis, since fat is less dense than lean tissue.
Liver density in the patients increased from -14.2 ± 22.3 HU at the beginning of the
study to 8.4 ± 10.3 HU after 2 weeks, and 9.6 ± 10.7 HU after 6 weeks. After 6
weeks of choline supplementation, there was essentially no hepatic steatosis in the
patients.
Pregnancy and lactation are also conditions that may be associated with
compromised choline status. A choline deficient diet in both pregnant and lactating
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rats results in significant decreases in liver phosphorylcholine, betaine, and free
choline as compared to non-pregnant/non-lactating rats on a choline deficient diet
(Zeisel, S.H, et. al. 1995). This demonstrates that pregnancy and lactation result in
increased risk for choline deficiency in rats. However, this has yet to be demonstrated
in humans.
Impairment of liver function seems to be consistent among all species, including
humans, during choline deficiency . It has been difficult to find cases of choline
deficiency in human populations because choline is plentiful in foods. It would be
difficult to construct a diet of natural foods that is choline deficient, this does not
mean, however, that choline is not essential - just easily obtained. Studies with
artificial diets suggest that choline may be an �ssential nutrient.

Camitine

L-camitine, L-f3-hydroxy-y-N-trimethylaminobutyric acid, like choline is a
quaternary, trimethylated amine. Camitine, again like choline, is synthesized de novo
in humans, and is available in the diet, though not as plentifully as choline (Broquist
1994). Carnitine was originally called vitamin BT but this terms is no longer used since
carnitine is not considered essential in the diets of higher organisms. Diseases of
camitine deficiency have been identified in humans (Broquist 1994), however, and
will be discussed later.
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Carnitine in the diet:

Dietary carnitine is derived primarily from animal food sources, and the average
nonvegetarian diet is estimated to supply 100-300 mg of carnitine per day (Broquist
1994). Vegetables, fruits, and grains are very poor sources of carnitine. Ground beef
has about 580 µmol of camitine per 100 grams whereas asparagus (one of the richest
vegetable sources) has about 1.2 µmol per 100 grams (Broquist 1994, Moukarazel et
al. 1992}.
Dietary intake of carnitine has been shown to have a significant influence on
carnitine status in humans. Children receiving total parenteral nutrition for 7.2 ± 2.6
years from birth had total plasma carnitine concentrations approximately half that of
other children of similar age (Moukarazel et al. 1992). When adults and children eat
either strict vegetarian diets, lacto-ovovegetarian diets, or mixed diets (including meat)
for long periods of time, both plasma camitine and urinary excretion of carnitine have
been shown to be affected (Lombard et al. 1989). Differences in plasma camitine
concentrations between groups were small but significantly lower in vegetarians .
Differences in urinary excretion of camitine were much greater, adult men on mixed
diets, lactoovovegetarian diets, or strict vegetarian diets excreted 5.79 ± 3.08, 2. 1 ±
0. 76, and 1.36 ± 0.49 µmol camitine per kg body weight per day, respectively. Similar
trends were seen for male children as well as female adults and children. The urinary
excretion of carnitine decreased proportionately with predicted carnitine intake. The
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subjects eating diets highest in carnitine had the highest excretion rate and those with
diets lowest in carnitine (strict vegetarian) had the lowest excretion rate.
How the differences in plasma carnitine and urinary carnitine excretion correlate
with tissue concentrations is not certain. It has been shown in rats that dietary
differences do substantially affect tissue concentrations, but were roughly proportional
to plasma concentrations, which had a much greater variation than seen in the above
mentioned human study (Negaro et al. 1 987).
To what extent humans rely on dietary carnitine is unknown. Cederblad and
Lindsted (1976) report that synthesis contributes four times more carnitine than does
diet in laboratory rats. In humans, however, dietary intake may be more important
since diet typically contributes 1 00-300 mg per day. The functional consequences of
variations in dietary intake of carnitine in humans are not known at this time, but it is
clear that dietary intake can affect plasma carnitine concentrations in humans and both
plasma and tissue concentrations in rats.

Intestinal absorption and tissue uptake of carnitine:

It has been difficult for researchers to determine the percentage of carnitine
absorbed from the diet. It was assumed for many years that carnitine was nearly 1 00%
absorbed because when labeled carnitine was given orally, little radioactivity appeared
in the feces. Kinetic analysis in animals and humans, however, indicated that there was
a higher rate of excretion than was reported (Brooks & McIntosh 1 975, Rebouche &
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Chenard 1 99 1 , Rebouche & Engel 1 983). In the kinetic studies, the carnitine was
given intravenously and no metabolites of carnitine were found in urine or feces.
However, when radioactively labeled carnitine was fed orally to rats as much as 34%
of the radioactivity was found in excreted metabolites (trimethylamine N-oxide and Y
butyrobetaine) of carnitine in urine and, to a small extent, in feces (Rebouche et al.
1984). When humans are fed radioactive carnitine 95% of the radioactivity is absorbed
from the intestinal tract, but several metabolites show up in the urine, primarily
trimethylamine N-oxide (Rebouche & Chenard 1 99 1 ). Apparently intestinal bacteria
degrade carnitine to other metabolites which are in tum absorbed and then excreted in
the urine. Recent studies indicate that carnitine is 54-87% absorbed without
degradation, depending on the dosage (Rebouche & Chenard 1 99 1 ).
Carnitine is absorbed both actively and passively across the intestinal mucosa
(Broquist 1994). Active carnitine absorption is a sodium-linked process similar to the
absorption of phosphate (Cheng & Sacktor 1 98 1 , Hamilton et al 1983, Stadler et al.
1 993 .). Carnitine enters the blood stream via the portal circulation and circulates as
free or acyl camitines (Broquist 1994). Most tissue cells transport camitine against a
concentration gradient resulting in a 1 0-100 fold greater intracellular concentration
(Broquist 1 994), suggesting an active transport mechanism.
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Carnitine biosynthesis:
Carnitine is synthesized from two essential amino acids in all mammals including
humans (Bieber 1 988). The nitrogen and carbon backbone of carnitine is derived from
lysine, and the methyl groups attached to the nitrogen originate from SAM. Table 2-1
shows the steps in carnitine biosynthesis, and the nutrients required as cofactors
(Broquist 1994, Cederblad et al. 1979, Henderson et al 1982, Lindstedt et al 1970,
Hulse and Henderson 1980).

Table 2- 1
Steps in the Biosynthesis of Camitine, and Nutrients Required

Step

Reactant

Product

Required Nutrient

1.

Lysine

N-trimethyl-lysine

Methionine, Lysine

2.

N-trimethyllysine

N-trimethyl-3hydroxylysine

Vitamin C, Iron

3.

N-trimethyl3-hydroxylysine

4-N-trimethylamino
butryaldehyde

Vitamin B6

4.

4-N-trimethylamino
butyraldehyde

4-N-trimethylamino
butyric acid

Niacin

5.

4-N-trimethylamino
butyric acid

L-carnitine

Vitamin C, Iron
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In step 1 lysine is methylated as a post-translational modification in proteins including
actin, myosin, and histones; and N-trimethyl-lysine is released as a result of enzymatic
degradation of those proteins (Broquist 1994, Broquist 1982, LdaBadie et al. 1976).
Steps 2-5 in Table 2-1 occur in both the liver and kidney in higher mammals (Broquist
1982, Sachan & Hoppel 1980, Rebouche and Engel 1980).
It is not clear how much effect diets deficient in the nutrients involved in camitine
biosynthesis have on camitine status. Wheat gluten diets (deficient in lysine) have little
effect on camitine concentrations in adult rats (Sachan & Mynatt 1993), however,
weanling rats fed a lysine deficient diet will become carnitine deficient (Khan & Bamji
1979, Tanphaichitr & Broquist 1973).
Vitamin C deficiency has also been proposed to impair carnitine status since it is
required for its biosynthesis. Vitamin C deficiency has been shown to result in
decreased activity of hepatic y-butyrobetaine hydroxylase and hepatic and renal a-N
trimethyllysine hydroxylase (Rebouche 1991). It was not determined, however, if the
effect on enzyme activity altered carnitine status. A subsequent study (Rebouche
1 995)

demonstrated that tissue camitine concentrations were reduced in scorbutic

guinea pigs, and that urinary excretion of carrutine was increased. However,
supplements ofradioactive tracers of the camitine precursor, e-N-trimethyllysine, were
converted to camitine more rapidly in the scorbutic guinea pigs than in controls. It was
concluded, therefore, that vitamin C deficiency causes camitine depletion by increasing
urinary excretion of carnitine and not by inhibiting its synthesis.
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Iron also has an obligatory role in camitine synthesis and a deficiency could impair
the process. Nutritional iron deficiency in pregnant rats results in hypertriglyceridemia
in both mother and pups, which can be reversed with iron supplementation (Sherman
et al. 1982). Pregnant rats continued on a iron deficient diet into the lactation period
produce milk with normal carnitine concentrations but reduced iron concentrations
(Bartholemy & Sherman 1 985). On day 2 after birth there was no difference in
carnitine concentrations in the pups, but on day 1 6 liver carnitine was about half that
of iron sufficient pups. Rat pups are not fully able to synthesize carnitine until 8 days
after birth (Hahn 1 981 ), so the effect of iron deficiency on their own camitine
synthesis would not be expected to be seen very soon after birth.
Marzo et al. ( 1994) found that plasma concentrations and urinary excretion of
camitine progressively decreased significantly in pregnant women. Plasma
concentrations dropped to approximately half the normal values for the same subjects
by week 3 6 of the pregnancy. The decreased plasma carnitine concentrations were
restored without intervention by one month after giving birth. These studies
demonstrate that iron deficiency may result in impaired carnitine synthesis and may

also explain the hypertriglyceridemia seen in the iron deficient pups.
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Carnitine and/atty acid metabolism:
The transport of long chain fatty acids across the inner mitochondrial membrane
into the matrix of the mitochondria (Figure 2-1) is the best characterized function of
carnitine (Fritz 1 963). This process involves the activation of a fatty acid by coupling
to coenzyme A via a thioester bond, followed by transfer of the acyl group to
carnitine, translocation of the acylcarnitine across the inner membrane, and transfer of
the acyl group to intramitochondrial CoA (Beiber 1988). The first step in carnitine
mediated transport of fatty acids across the inner mitochondrial membrane is the
cytosolic generation of acyl CoA which diffuses across the outer membrane into the
inter membrane space.
Carnitine palmitoyltransferase I (CPT l) spans the outer mitochondrial membrane,
with the transferase active site on the inside of the membrane and a malonyl CoA
binding site on the cytosolic side. The active site transfers the acyl group of the acyl
CoA to carnitine to make an acylcarnitine (Bremer 1983). Binding of malonyl CoA to
the cytosolic side of the CPT 1 inhibits the enzyme and assures that acyl groups will
not be transported into the mitochondria for oxidation at the same time that fats are
being synthesized (Brady et al 1993). Carnitine-acylcarnitine translocase shuttles the
acylcarnitine across the inner mitochondrial membrane where another CPT (CPT2)
transfers the acyl group back to intramitochondrial CoA after which it proceeds to
oxidation (Broquist 1994). The reverse of the process for transporting long chain
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Figure 2-1 : Role of camitine in the translocation of acyl groups across the inner
mitochondrial membrane into the mitochondiral matrix for oxidation.
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fatty acids into the mitochondrial matrix appears to be used for removing short and
medium chain fatty acids from the inside of the mitochondria (Beiber 1 988, Broquist
1 994). This function ofremoving short-chain fatty acids from the mitochondria may be
related to the observed increases in acid-soluble acyl carnitine (ASAC), short-chain
acyl carnitine, in serum and urine of humans and rats during fasting (Frohlich et al
1978 and Seecombe et al 1978). Free, or non-esterified, camitine (NEC) is decreased
in serum during fasting and is inversely correlated with both serum free fatty acid and
,8-hydroxybutyrate concentrations (Frohlich et al 1 978). Increased ASAC, with a
concomitant decrease in NEC; during fasting, suggests that increased fatty acid
oxidation may result in a shift in body pools from non-esterified to esterified carnitine.
The correlation of ASAC and inverse correlation of NEC with serum free fatty acids
and ,8-hydroxygutyrate suggests that increases in the ratio of ASAC/NEC are
indicative of an increase in the oxidation of fatty acids.

Other possiblefunctions of carnitine:
The concentration of carnitine in the brain is lower than most tissues, but still
significant (Rebouche 1986). The function of camitine in the brain is unknown since
the brain is not believed to utilize fatty acids for energy. Recent studies have
investigated the use of acetylcarnitine for treatment of neurological disorders. In
streptozotocin induced diabetic rats, treatment with acetylcarnitine was able to reverse
neurological damage as determined by measurement of nerve conductance velocity
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(Morabito et al. 1993). In aged rats, acetylcarnitine was able to restore neuromuscular
conduction velocity to that of young rats after 6 months of treatment (Scarfo et al.
1992). Human tests with Alzheimer's disease patients have shown some evidence that
acetylcamitine may ameliorate the symptoms of the disease when given orally (Sano et
al. 1992). How acetylcamitine may exert the effects reported on neurological function
is unknown.
The organ most sensitive to carnitine deficiency is the heart, because the heart relies
on fatty acids for about 60% of its energy needs (Rebouche 1 986). Primary camitine
deficiency is a rare syndrome that has been described in children (Pierpont 1992). In
this disease plasma camitine concentrations are very low resulting in congestive
cardiomegaly which can be reversed by oral carnitine administration. Cardiomegaly
can also develop as a result of carnitine being dialyzed out of the blood in hemodialysis
patients, and camitine should be supplemented in such patients (Kudoh et al. 1983).
The use of camitine has been investigated for treatment of ischemic heart disease, but
the results thus far have been contradictory so it is still under investigation (Rebouche
1 986).
Camitine has also been shown to reduce the hepatic steatosis seen in chronic
alcoholic rats (Sachan & Rhew 1 983). Rats fed a diet with 36% of the calories from
alcohol will accumulate 3-4 times the hepatic lipid content of controls within 8 weeks.
Rats supplemented with D,L-camitine ( 1 % by weight in the diet or 0.5% L-camitine)
accumulated less than half the lipids as did the non-supplemented alcoholic rats. The
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effect of camitine on liver lipids was later shown to be dose dependent with the
greatest effect at 0.8% D,L-camitine in the diet (Rhew & Sachan 1 986). Camitine was
also shown to reduce the rate of alcohol disappearance from the blood (Sachan &
Berger 1 993). The effect was not seen with choline supplementation although choline
is very similar in structure to camitine (Sachan & Berger 1993). It was concluded that
the attenuation of ethanol metabolism was specific for carnitine. The reduced rate of
ethanol clearance was shown to be the result of reduced ethanol oxidation, even
though the activity of ethanol oxidizing enzymes was unaffected (Mynatt & Sachan
1 992).
The hepatic steatosis resulting from aflatoxin B 1 or CC4 administration has also
been shown to be reduced by camitine supplementation (Sachan et al. 1 993, Sachan
and Dodson 1 992, Yatim and Sachan 1992). Carnitine also reduced formation of
aflatoxin adducts with RNA, DNA, and proteins in the liver (Yatim and Sachan 1 992).

Carnitine excretion:

At normal plasma concentrations, about 90% of the carnitine filtered in the kidney is
reabsorbed (Engel et al. 1 981 ). The macronutrient content of human diets is known to
affect both urinary excretion of carnitine and plasma carnitine concentrations. High fat
diets have been shown to increase both plasma concentration and carnitine clearance
over low fat diets (Cederblad 1 987). Plasma carnitine concentrations tend to remain
rather constant at a wide range of dietary intake, and it appears that renal adaptation to
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carnitine intake is a major regulator of plasma carnitine concentration (Katrib et al.
1 987). Persons given a diet high in fat, protein, or both excrete significantly increased
amounts of carnitine (Rebouche et al. 1 993). In that study, the increased carnitine
excretion appeared to be the result of increased plasma carnitine concentration
resulting an increased filtered load. Carnitine intakes were constant between groups so
the diet apparently resulted in increase in either carnitine absorption, biosynthesis, or
release from tissue stores.

Camitine-Acyltransferases

Although carnitine was discovered as a nitrogenous compound of muscle
tissue in 1905 (Fraenkel, G. and Friedman, S. 1 905), it was not until 1 955 that its
function began to be understood. Fritz ( 1 955) demonstrated that carnitine was the
active component of muscle that was known to increase fatty acid oxidation in liver
(Lundsgaard, E. 1950). In 1 963 coenzyme A dependent formation of palmitioyl
carnitine in mitochondria was demonstrated (Bremer, J. 1 962) as well as camitine

dependent oxidation of palmitoyl-coenzyme A with palmitoyl-carnitine as an
intermediate (Fritz and Yue 1 963).
As researchers isolated and characterized the carnitine acyl-transferases it became
clear that there was more than one, based on substrate specificity (Bremer 1 983 ).
Although the issue is not yet resolved, at least three distinct enzymes are known to
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exist, carnitine-acetyltransferase, camitine-octanoyltransferase, and camitine
palmitoyltransferase (Broquist 1994).

Carnitine-acetyltransferase
Carnitine-acetyltransferase (CAT) catalyzes the transfer of short-chain acyl groups
from acyl-CoA to camitine to make acylcamitines. The Km of CAT for acetyl-CoA is
37 µM and nearly the same for other acyl-CoAs regardless of chain length. The
reaction rate, however, in pigeon breast muscle (a common commercial source of
CAT) is greatest for acetyl-CoA and decreases with increasing chain length of the
acyl group with decanoyl-CoA having only about 4% of the activity of acetyl-CoA
(Bremer 1983, Chase 1967, Chase and Tubbs 1966).
Depending on the species, CAT has a molecular weight ranging from 55,000 - 62
kDa (Bremer, 1983). Two forms of CAT are found in rat liver, mitochondrial and
peroxisomal. The two are encoded by the same gene but have divergent sequences at
the 5' end, the apparent result of alternative splicing mechanism which determines the
subcellular localization of the gene product (Corti et al. 1 994).
The functions of CAT are not clearly understood, but the most common function
attributed to mitochondrial CAT is the regeneration of free CoA by the removal of the
acyl groups from short-chain acyl CoA in the mitochondrial matrix (Broquist 1994).
Another possible function is to facilitate the excretion of toxic short chain organic
acids. Such short chain organic acids may be the result of normal energy metabolism,
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abnormal energy metabolism (propionic acidemia and methylmalonic acidemia), or
drug therapy (pivalic acid and valproic acid) and their excretion as carnitine esters, if
excessive, can result in a secondary carnitine deficiency (Broquist 1994, Rebouche
1986).
Carnitine and acetylcarnitine have also been suspected of playing a role in the
production of the neurotransmitter, acetylcholine, either directly or indirectly as a
shuttle for acetyl groups from the mitochondria to the cytosol, where acetylcholine is
formed (McCaman et al. 1 966). Patients suffering with Alzheimer's disease have been
shown to have decreased CAT activity in the brain (Kalaia and Harik 1 992) and
Alzheimer's patients treated with acetyl-carnitine have been shown to have a reduced
progression of the disease (Spagnoli et al. 1 991).
Whether the above roles for carnitine are essential or just facilitory has not been
clearly established (Broquist 1 994). The presence of CAT in high concentrations in
muscles such as heart and flight muscles, which rely heavily on fat oxidation for
energy, may suggest that it is essential for the mitochondrial regeneration of free
CoA, however.

Carnitine-octanoyltransferase

Carnitine-octanoyltransferase (COT) is a 60 kDa protein that has been found in
the mitochondria, peroxisomes and microsomes of mouse liver (Bremer 1983,
Broquist 1994). It has a broad substrate range, overlapping with CAT and CPT. The
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Km of COT for octanoyl-CoA is 1 5 µM. Octanol-CoA is the best substrate for COT
with acetyl-CoA and palmitoyl-CoA having reaction rates of 26% and 8 % of that of
ocatanoyl-CoA (Bremer 1983). The functions of COT are less understood than for
either CAT or CPT.

Carnitine-Palmi.toyltransferases

There are two distinct CPT enzymes in cells, both of which reversibly catalyze the
reaction Camitine + Acyl-CoA � Acyl-Camitine + H-S-CoA (Bremer 1 983,
Hoppel and Tomec 1 971, Murthy and Pande 1994). One CPT, hereafter referred to
as CPT-1, is a transmembrane protein located in the outer mitochondrial membrane.
The other CPT, CPT-11, is bound to the inner surface of the inner mitochondrial
membrane. Although both enzymes are capable of catalyzing the above reaction in
both directions, under normal physiological conditions CPT- 1 catalzyes the formation
of acyl-camitines from acyl-CoA's and CPT-11 the reverse reaction (Figure 2-1).
CPT activity has also been located in peroxisomes and rnicrosomes of cells
(Bhuiyan et al. 1 994, Murthy and Pande 1 994) and appear to be distinct proteins from
the mitochondrial CPT' s. The function of peroxisomal and microsomal CPT has not
been well characterized. It does not appear that either carnitine or CPT are required
for the transport of acyl groups into peroxisomes; there is, however, evidence that
carnitine may be involved in the shuttling of proprionyl-CoA from peroxisomes to
mitochondria for further oxidation (Jakobs and Wanders 1 995). Because little is

24

known about non-mitochondrial CPT, only mitochondrial CPT will be discussed
further.

Carnitine Palmitoyltransferase-1

CPT-1 occurs in at least two isoforms in rats, a liver CPT- 1 ( = 8 8 kDa) and
skeletal muscle CPT- 1 (=82 kDa) (Britton et al. 1 995). The cDNA for human liver
CPT-1 has been recently cloned and sequenced and the genomic location determined
to be on the q (long arm) of chromosome 1 1 (Britton et al. 1995). Mitochondrial
CPT-I has been proposed to catalyze the rate limiting step in fatty acid oxidation, and
regulation of its activity to be pivotal in the determination of energy substrate
utilization (McGarry and Foster 1980). Brady et al. (1 993) have suggested, however,
that mitochondrial CPT- 1 should not be considered rate limiting in fatty acid
oxidation. They suggest that acyl-camitine formation is actually rate limiting, and that
acyl-camitines may be the product of microsomal CPT as well as mitochondrial CPT.
The application of molecular cloning techniques over the last 5 years has clarified two
long-standing controversies regarding CPT. First, for many years it was debated if
CPT- 1 and CPT-2 were different proteins or if they were one protein with two
different catalytic sites. It is now clear that they are two different proteins with
separate functions and control mechanisms. Second, the issue of how CPT-I and
CPT-II compare across tissue line·s is partly resolved. It is now known that at least
two different CPT-1 isotypes exist. L-CPT-1 , is found in liver, kidney, and
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fibroblasts. M-CPT-I, is found in skeletal muscle, adipocytes, and is the predominant
CPT-I in heart, although heart expresses both types. The two types of CPT-I are
known to exhibit very different kinetics and inhibition sensitivities. The physiological
implications of the different regulatory characteristics of CPT-I isotopes are just
beginning to be understood (McGarry 1 995).
CPT-1 in is known to be regulated in 3 ways.
1. By malonyl CoA inhibition (Bremer 1983).
2. By changes in the sensitivity to malonyl CoA (Cook 1984, Cook et. al. 1984).
3. By changes in the amount of the enzyme present, a result of changes in the rate of
transcription and translation of the protein ( Chatelain et al. 1 996, Mynatt et al.
1 994).
The inhibition of CPT-1 by malonyl CoA, the product of the first committed step in
fatty acids synthesis, represents a negative regulation which insures that fatty acids
are not being simultaneously synthesized and oxidized (Brady et al 1993). Changes in
the malonyl CoA inhibition are a short-term regulatory mechanism, while increases in
the rate of translation and transcription of CPT-1 represent a more sustained
response, and is typically seen in starvation and diabetes (Brady et al 1993) . An
unusual property of CPT-1 is that it is also inhibited by high concentrations of
palmitoyl CoA, of one of its substrates (Bremer 1983, Zierz and Engel 1995).
CPT-1 has a reported apparent Km for camitine of

= 150 µmol/L (Murthy and

Pande 1992, Kolodziej, M.P., et al. 1992), but shows considerable variation between
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species and tissues with reported values as low as 32 µmoVL for rat liver but 507
µmoVL in muscle from the same animals, and 695 µmoVL for dog heart (McGarry et
al. 1 983) . The reported apparent Km ofCPT-1 for palmitoyl-CoA is considerably
more uniform, at least in rat tissues, with 30 and 60 µmoVL being reported for rat
liver and skeletal muscle respectively (McGarry et al 1 983).
Although CPT-1 in all tissues appears to be inhibited by malonyl CoA, there
appears to be two distinct isotypes with different sensitivities to malonyl CoA. The
CPT-1 of liver and kidney are one type whereas that of skeletal muscle and adipose
tissue are a slightly smaller protein which is much more sensitive to malonyl CoA
(Brady et al. 1 993, Esserson et al. 1 996, Saggerson et al. 1981, ). Rat heart contains
both liver and muscle CPT-1 (Brown et al. 1 995). In neonatal rats the liver isoform
contributes about 25% the total CPT-1 activity, but decreases with age to about 4%
in adult animals.

Carnitine-Palmitoyltransferase-11

CPT-II occurs as only one isotype in all tissues and is =68-kDa in size (Brady et
al 1 993). As previously mentioned, CPT-11 can catalyze bi-directionally. The CPT-11
Km for carnitine, however, is about 1 0 times higher than for CPT-I (1 .5 mmol/L)
assuring that the reaction will always predominate in the reverse direction under
physiological conditions (Brady et al 1 993). Unlike CPT-I, CPT-II is not inhibited by
malonyl CoA, and all changes in activity appear to associated with corresponding
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changes in the amount of protein present as well as the level of expression of its
mRNA as determined by northern blots, and nuclear transcription rates as determined
by nuclear run-on assays (Brady et al 1 993). The human chromosomal CPT-II gene
has not been yet been cloned (cDNA for the gene has been cloned) but it has been
localized to the p32 region of chromosome 1 (Britton et al. 1 995).

Interactions Between Nutrients

The concept of a nutrient interacting with another nutrient in ways that affect the
tissue concentrations or dietary requirement for that nutrient is not new. It was
reported in 1 947 that dietary tryptophan reduces the dietary requirement for niacin
(Krehl 1 947, Young & Fukagawa 1 988).

Interaction between vitamin C and iron:

A classical nutrient-nutrient interaction is that between vitamin C and iron.
Vitamin C is able to increase the absorption of iron by keeping it in the reduced (Fe2+)
state, and by chelating it and keeping the iron in a more soluble form (Hallberg 1981).
Vitamin C is also important in other aspects of iron metabolism such as synthesis of
hemoglobin and the removal of iron from ferritin (Hallberg 1 98 1 ).
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Interaction between calcium and magnesium:
Similar nutrients often affect each other, such is the case with the two divalent
cations calcium and magnesium. It has been reported that increasing the calcium
consumption in humans can reduce absorption of dietary magnesium (Kim &
Linkswiler 1 980). In rats fed a parenteral nutrition diet with graded doses of calcium,
urinary excretion of magnesium increased as calcium supplementation increased (Al
Jurf & Chapman-Furr 1 985). Calcium, therefore, may decrease absorption and
increase excretion of magnesium simultaneously.

Interaction between choline and carnitine:
Choline and carnitine are also very similar in structure as shown here.

(CH3)3-N-CHi-CH-CH2-COOH

I

OH
Carnitine

Choline

With such striking similarity, it would not be surprising if interactions were found.
Rats that are fed a choline deficient diet have been shown to have reduced carnitine
concentrations in liver, heart, and skeletal muscle, but increased plasma carnitine
concentrations compared to animals fed a choline supplemented diet (Carter & Frenkel
1 978). Comparisons were not made to a control diet in this study.
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Choline deficiency results in a decrease in lipid oxidation in heart and liver cells
that can be reversed in vitro by the addition of carnitine (Corredor et al. 1967). The
difference in carnitine levels in this study were even more dramatic after the animals
were fasted for 48 h. Carnitine concentrations increased almost four fold in liver and
significantly in heart and muscle after fasting of the choline supplemented animals. In
the choline deficient animals camitine increased in the liver about 3 fold but decreased
only slightly in heart and muscle. It would appear that increases in carnitine
concentrations are a part of the adaptation to fasting that is impaired when there is
choline deficiency in rats.
It was shown in another study that the decreased hepatic carnitine in choline
deficient rats results in a four fold decrease in oxidation of 14C palmitate and an
increased incorporation into triglyceride in liver homogenates (Corredor et al. 1967).
Addition of carnitine, but not choline, in the liver homogenates restored palmitate
oxidation to control levels and decreased the rate of esterification of palmitate to
glycerol. This suggested that the fatty liver seen in choline deficient rats may be due in
part to a lack of carnitine.
Two enzymes, choline-acetyltransferase and carnitine-acetyltransferase, also
exhibit similarities, catalyzing the transfer of acetate from acetylcoenzyme A to
choline and carnitine respectively. Carnitine-acetyltransferase has weak choline
acetyltransferase activity, but choline-acetyltransferase is not cross reactive (Sastry &
Janson 1994).
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Choline and pantothenic acid supplementation has also been shown to reduce
carnitine concentrations in plasma and 24 hr urine of humans (Mynatt et al. 1 988,
Dodson & Sachan, 1 992). Follow-up studies demonstrated that the effect on carnitine
was due to choline and not pantothenic acid (Sachan et al. 1 993, Dodson and Sachan
1 996). The results of these studies raised a number of intriguing questions which could
not be adequately answered by reasonable experiments in humans. The questions
included 1) Are the decreases in plasma and urine carnitine concentrations a reflection
of choline-induced carnitine deficiency or an altered partitioning of carnitine among
tissues? 2) Is choline effect mediated via the carnitine transporters in tissues? 3) What
are the consequences of the decreased carnitine concentrations in plasma and urine?
A need for an animal model was clearly realized and a series of studies was
initiated for the purpose of finding a good animal model to study the choline-carnitine
interactions. An animal model was established, and is discussed in the next chapter.
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Chapter 3
Preliminary Research and Objectives

The observation that choline and pantothenic acid supplementation resulted in a
decrease in camitine excretion to less than half that of unsupplemented subjects raised
several interesting questions. First, was this a supplement induced carnitine deficiency,
and if so which supplement? Some individuals had normal or higher plasma carnitine
concentrations while others had lower concentrations, plasma data were inconsistent
(Dodson and Sachan 1996). Supplemental camitine, in both control subjects and
those supplemented choline and pantothenic acid, increased urinary carnitine
excretion above baseline values. However, carnitine excretion in the choline and
pantothenic acid supplemented subjects was still about half that of controls.
There was no way of knowing how body carnitine pools other than urine and
plasma were being affected, therefore an animal model was needed to study what
effect choline was having on tissue concentrations and the total body pool of
carnitine.
Rats were first used as an experimental model to study the interaction of choline
and pantothenic acid on carnitine in humans. There was no effect of either choline,
pantothenic acid, or both combined on either urinary excretion or plasma
concentration of carnitine in rats (Daily and Sachan 1995). It was postulated that the
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lack of effect in rats might be due to their high liver choline oxidase activity (Table 31 ). The animal with the choline oxidase activity nearest that of humans is the guinea
pig. Guinea pigs were less convenient because of difficulty in drawing blood, but
would hopefully respond similarly to humans when supplemented with choline.

Table 3-1
Liver Choline Oxidase in Selected Species

Species

Choline Oxidase Activity
2408 ± 121
13 1 1 ± 8
895 ± 72
361 ± 63
144 ± 2 1
1 3 6 ± 43

Rat
Chicken
Mouse
Hamster
Monkey
Guinea Pig
Human

40 ± 7

1

Taken from Sidransky and Farber (1 960). Activity units are in microliters of 02
uptake/brig wet liver ± SEM.
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Pantothenic acid had no effect on either urinary excretion or plasma concentration
of carnitine in guinea pigs (Daily and Sachan 1 993). Choline supplementation (3g/kg
diet), however, resulted in a significantly lowered carnitine excretion, similar to that
seen in humans (Table 3-2). Plasma concentrations of carnitine were significantly
higher in the choline supplemented group than in the non-supplemented group at the
end of the study. This was different than what was seen in humans. Human studies had
shown a trend toward a decrease in plasma carnitine concentrations with choline
supplementation (Mynatt et al. 1988). A subsequent human study has clearly
demonstrated, however, that choline affects human plasma carnitine concentrations
differently for different individuals, some increasing and some decreasing (Dodson and
Sachan 1 996).
The decreased excretion of carnitine in humans and guinea pigs had several
possible explanations. Since there was no consistent change in plasma concentrations
of carnitine in humans, the decreased excretion would suggest a conservation of
carnitine, or a decrease in available carnitine. One possibility was that absorption of
dietary carnitine was impaired by choline supplementation. However, the camitine
content of the guinea pig diet was so low that it was not detectable, therefore,
impaired absorption would have no significant affect on the guinea pigs if that were
the cause.
Another possibility was that carnitine synthesis was impaired. However, it has
never been shown that carnitine synthesis is impaired by choline. In fact,
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Table 3-2
Effect of Choline Supplementation on Urinary Excretion
and Plasma Concentration of Carnitine in Guinea Pigs 1
Level of Choline
Supplement

Camitine

NEC
(g/kg diet)
0
3

ASAC

AIAC

TOTAL2

Day O of Study, Urinary Excretion (µmoVd)
1.3 ± 0.2
1.5 ± 0.2

0.9 ± 0.2
0.8 ± 0.2

0.1 ± 0.01
0.1 ± 0.03

2.2 ± 0.3
2.4 ± 0.3

Day 5 of Study, Urinary Excretion (µmoVd)
0
3

1. 5 ± 0.2
0.4 ± 0.1 *

0.6 ± 0.1
0.3 ± 0.0*

0.1 ± 0.01
0.1 ± 0.01

2.6 ± 0.4
0.8 ± 0.1*

Day I O of Study, Urinary Excretion (µmoVd)
0
3

1. 7 ± 0.1
0.5 ± 0.1*

0.8 ± 0.2
0.5 ± 0.1

0.1 ± 0.01
0.1 ± 0.01

2. 5 ± 0.3
1.1 ± 0.1 *

Day IO of Study, Plasma Concentration (µmoVL)
0

3

38.1 ± 2. 1
47.2 ± 1.8*

1 6. 1 ± 4.3
30.8 ± 6.0

I . I ± 0.2
0.9 ± 0.1

54.4 ± 4.5
74.0 ± 5.9*

Values are means ± SEM for the groups. Guinea pigs were fed grount diet with
either no supplement or 3 g/kg choline from choline chloride for 10 days (diet
contained l .85g/kg choline without added supplement). On d O (pre-experimental
diet) and d 5, n = 12 for both groups; on day 10, n = 6 for the choline supplemented
group and n = 6 for the non-supplemented group.
An asterisk indicates significant difference between the supplemented and non
supplemented groups (P ::; 0.05) by Student's t test.
2
NEC = non-esterified camitine, ASAC = acid-soluble acyl carnitine, AIAC = acid
insoluble acyl carnitine, Total = total carnitine (Daily and Sachan 1995).
1
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just the opposite occurs in rats, choline deficiency impairs carnitine synthesis (Carter &
Frenkel 1 978). Comparing carnitine biosynthesis between groups in a definitive
manner is not possible. Frequently, rates of synthesis can be compared by comparing
the activity of biosynthetic enzymes. Carnitine biosynthesis, however, does not appear
to be enzymatically regulated. Rather, it appears to be regulated by release of
trimethyllysine as proteins are broken down (Sandor & Hoppel 1 989, Sandor 1990). If
decreased carnitine biosynthesis is responsible for the decreased excretion of carnitine
in choline supplemented humans and guinea pigs, that might be reflected in decreased
tissue concentrations of carnitine.
To explore that possibility, another group of guinea pigs was studied for the
purpose of obtaining more tissue samples. Blood collections were taken during the
course of this study, instead ofjust at the end. Urinary excretion of free and total
carnitines were reduced in the choline supplemented group as before, but acyl
carnitines were elevated in both groups but more so in the choline supplemented group
(Daily and Sachan 1 995). No tissue carnitine concentrations were lower in the choline
supplemented group, and the camitine concentration was significantly higher in
skeletal muscle (Figure 3-1 ). This demonstrated conclusively that there was not a
choline-induced carnitine deficiency in guinea pigs.
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Figure 3-1: Effect of choline supplementation on tissue concentrations of total
carnitine in guinea pigs. Each group was fed guinea pig diet either supplemented
(ChS group) with choline (3g/kg diet) or with no supplement (NS group). Values
are group means ± SEM (n = 12). Significant difference between groups by
Student' s t test is indicated by an asterisk (Daily & Sachan, 1 995).
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· Plasma �-hydroxybutyrate was also higher in the choline supplemented guinea
pigs (Daily & Sachan 1 995). This raised two questions. First, were the serial blood
collections (by cardiocentesis) under anesthesia responsible for the increase in acyl
camitine and �-hydroxybutyrate? This was later confirmed in a study of the effect of
anesthesia and cardiocentesis on urinary excretion (Park et al. 1995, Park et al. 1996).
Second, if the anesthesia and blood collection were responsible, did the higher plasma
�-hydroxybutyrate and urinary acyl-carnitine indicate that choline supplemented
guinea pigs have an increased capacity for fatty acid oxidation?
Only one dose of camitine in humans (20mg/kg body weight) and another in
guinea pigs (3g/kg diet) had been used in these studies. The human dose was based on
the amount used by the individual in which the choline effect was first observed
(Dodson and Sachan 1 996, Mynatt et al. 1 988). The dose used in guinea pigs
represented a similar percent increase over normal dietary choline as was shown to be
effective in humans, thereby demonstrating a similar effect with similar increases in
choline intake. What level of choline supplementation is required to be effective, and
how much is required for a maximal effect, remained unanswered.
The following studies were designed to address: 1) the possible functional
consequences of this newly discovered choline-camitine interaction on fatty acid
oxidation in guinea pigs, and 2) the minimal choline dose required to obtain the effect
on carnitine status, and the dose which yields the maximal effect.
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Chapter 4
Effect of Varied Choline Doses on Plasma, Urinary
and Tissue Carnitine in Guinea Pigs

Introduction

Choline and carnitine are two trimethylated quaternary amines that are very
similar in structure, but without many similarities in function. Both use different
transport proteins for intestinal and renal absorption. Both can be acetylated by
similar CoA-dependent acetyl-transferase enzymes, but for different purposes. In the
past, studies of choline-carnitine interactions have evaluated the effect of choline
deficiency on carnitine status (Aarsaether et al 1 988, Carter and Frenkel 1 978,
Corredor et al 1 967). These studies have demonstrated that choline deficiency in rats
result in a decrease in liver, heart and skeletal muscle carnitine, and that fatty acid
oxidation is impaired. We, however, have demonstrated an effect of choline
supplementation in excess of normal dietary intake on carnitine homeostasis (Daily
and Sachan 1 995, Dodson and Sachan 1 996). Choline supplementation in humans
(20 mg/kg body weight) and guinea pigs (3 g/kg diet) results in a decrease in urinary
excretion of carnitine to less than half normal values. In these studies, plasma carnitine
concentrations were variably affected in humans, but were increased in guinea pigs.
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Tissue concentrations of camitine were also affected in guinea pigs, with choline
supplementation causing a significant increase in skeletal muscle camitine; however,
tissue carnitine concentrations have not yet been determined in humans.
The choline dose in the above human study was based on what was observed in a
person using a choline supplement in which the effect on carnitine was first observed
(Dodson and Sachan, 1 996). The levels of choline supplementation in guinea pigs
reflected a similar increase over normal dietary choline levels (the level of supplement
was approximately 1 . 7 times that found in the diet). In neither species, however, has
either a minimal effective choline dose or the level of choline supplementation for
maximum effect been determined. The primary objective of this study was to
determine such dose effects in guinea pigs.
Low carnitine excretion in humans is frequently the result of a low dietary intake
of carnitine. Low dietary intake of carnitine in choline supplemented guinea pigs can
not be the reason for reduced excretion of carnitine because the guinea pig diet is
essentially carnitine free (Daily and Sachan 1 995). It is possible that if carnitine were
being lost from the intestinal tissue, excreted into the intestinal lumen, and then not
reabsorbed, that a reduced urinary carnitine excretion could be a compensatory
mechanism to preserve camitine. An intestinal loss into the lumen would be expected
to result in a decrease in gut tissue camitine with a simultaneous increase in camitine
in the lumen contents, and possibly fecal carnitine. Therefore, a secondary objective
was to evaluate the likelihood of intestinal loss of camitine by determining its
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concentrations in intestinal tissue, lumen contents, and feces. Additional secondary
objectives of these studies were to I) determine the effect of choline on total body
carnitine, 2) determine the effect of choline on body composition, and 3) determine
the effect of choline on feed efficiency in guinea pigs.

Materials and Methods

All research protocol for these studies were approved by the Animal Care and Use
Committee of the University of Tennessee. Prior to the dose response study an attempt
was made to use a semi-purified diet for the dose response study. Ten male, nine week
old, Hartley guinea pigs (SASCO, Inc; Omaha, NE) were divided into two groups of
five and fed either ground commercial guinea pig diet (Purina Guinea Pig Chow no.
5025, Purina Mills, Richmond, IN) or a semi-purified diet (Table 4-1). With one
exception, the guinea pigs did not eat the semi-purified diet, and the one that did eat,
consumed less than the animals on the control diet (Table 4-2). The self-induced
starvation resulted in an average weight loss of almost 40 grams in 5 days, during the
same period the animals on the commercial diet gained an average of about 30 grams.
For one day, the semi-purified diet was supplemented with 4% alfalfa flour, but this
resulted in only a small change in acceptance of the semi-purified diet by one animal
(Table 4-2). It was decided that the guinea pigs would not eat a semi-purified diet
normally, and that using a choline supplemented commercial diet, as used in previous
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Table 4-1
Composition of Guinea Pig Semi-Purified Diet
Ingredient

g/kg Diet

Soy Protein
L-Arginine
D,L-Methionine
Com Oil
Com Starch
Sucrose
Glucose
Mineral Mix
AIN Vitamin Mix
Ascorbate
Choline Chloride
Alphacel

200.00
3 .00
5.00
50.00
1 50.00
1 40.00
1 20.00
67. 50
10.00
1 .00
2.47
25 1 .03
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Table 4-2
Food Consumption and Weight Gain or Loss in Guinea Pigs
Fed Ground Commercial Diet or Semi-Purified Diet 1

Groups

1

Commercial Diet

Semi-Purified Diet

Feed Consumption (g/d)
Prior to Experimental Diets

30.80 ± 1 . 1 0

30.90 ± 0.84

Feed Consumption (g/d)
While on Experimental Diets

3 1 .24 ± 1 .61

5 . 56 ± 1 . 80

Feed Consumption (g/d) While on Semi-Purified
Diets With 4% Alfalfa Added

8.00 ± 4.59

Weight Change (grams)
During Experimental Period

- 39.4 ± 12.77

+ 29.6 ± 7.22

Values shown are the means for the group over 5 days ± SEM.
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studies, would be more satisfactory. Because this was a dose response study, it would
be undesirable for daily choline intake to be determined by the willingness of animals
to eat normally rather than the choline concentration of the diet. Other researchers
have also experienced difficulty in getting guinea pigs to eat semi-purified diets. For
example, Teo et. al. ( 1991) reported that weanling male Hartley guinea pigs had to be
selected for their adaptability to a semi-purified diet.
Of the ten guinea pigs, 2 were transferred to another study and the 8 remaining
were divided into four groups of two and used for the first of two trials in the dose
response study. After completing the study with the first 8 guinea pigs, 12 additional
male Hartley guinea pigs ( 5 week old) were purchased and divided into 4 groups of 3
to complete the study with a total of 20 guinea pigs. All animals were individually
housed in stainless steel wire mesh cages except when urine was being collected. All
animals were allowed free access to water and feed ( Purina Guinea Pig Chow no.
5025, Purina Mills, Richmond, IN) for one week prior to the beginning of the study,
and to water and their respective diets during the study
There were four groups of five guinea pigs assigned to one of the four doses of
dietary choline supplement. Experimental diets were prepared by grinding guinea pig
diet and adding either no choline or 2, 5, or 1 0 g choline from choline chloride per kg
diet (Table 4-3). Since the diet contains endogenous choline of approximately 1 . 85
g/kg diet, this represents a range from approximately 2 - 12 g/kg diet.

44

Table 4-3
Choline Content of Control and Experimental Guinea Pig Diets

Experimental Groups

Choline from Diet (g/kg)
Choline Added to Diet (g/kg)
Total Choline in Diet (g/kg)

NS

2ChS

5ChS

l OChS

1 .85
0.00
1 . 85

1.85
2. 00
3.85

1.85
5.00
6.85

1.85
1 0. 00
1 1.85

The first set of guinea pigs included those that had been on the semi-purified diets
and began the study after the group on semi-purified diets regained their weight and
were comparable in weight with the guinea pigs fed the commercial diet. The second
set of guinea pigs was placed on experimental diets one week after arrival.
Throughout the study, records were kept of food consumption and weight gain.
Feed efficiency was calculated as the amount of weight gained in grams per gram of
feed eaten (g weight gain/g feed eaten). Urine was collected before beginning the
experimental diets and on days 2, 5, 1 4, and 2 1 and feces collected on day 2 1 of the
dietary treatment. Urine was collected by placing the animals in acrylic metabolic
cages for 24 hours with a urine collector containing 1 ml of O .2 mol/L HCI. Blood was
collected by cardiac puncture under open drop methoxyflurane anesthesia on day 2 1 .
The blood was centrifuged and the plasma frozen at -20°C until assayed. Following the
blood collection, the guinea pigs were killed by decapitation while still under
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anesthesia. The small intestine was clamped at the ilea! and duodenal ends, surgically
removed and the lumen contents flushed twice with 1 0 ml of saline and the flush saved
for carnitine assay. The intestine was then divided into 3 segments and each segment
measured, weighed, and frozen at -80°C until assayed for carnitine. Heart, brain,
kidneys, liver, and gastrocnemius muscle were also removed, and stored at -80°C for
carnitine assay. Animal carcasses were saved and frozen at -80°C for proximate
analysis and total body carnitine determination.

Carniti.ne Assay:

Carnitine was assayed in blood, urine, and tissue samples by a modified
radioisotopic method of Cederblad and Linstedt (Cederblad and Lindstedt 1972,
Sachan et al. 1 984). In this assay, acid insoluble long-chain acyl carnitines (AIAC) are
precipitated using perchloric acid, leaving the short-chain acid soluble acyl carnitines
(ASAC) and the non-esterified camitines (NEC) in the supernatant. An aliquot of the
supernatant is assayed to determine the NEC concentration and another hydrolyzed
with 0. 5 N KOH to assay all acid soluble carnitines. ASAC is the difference between
the total acid soluble carnitines and the NEC. The pellets are drained, washed,
suspended in 0.5 N KOH, and hydrolyzed in a water bath at 60°C for 60 minutes and
assayed for carnitine.
In each case carnitine is determined by using carnitine acetyl transferase (Sigma
Chemical Co., St Louis, MO) to esterify carnitine to a 14C-acetate from 1, 14C-acetyl
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CoA (Moravek Biochemicals, Brea, CA). Unreacted 14C-acetyl CoA is removed from
the reaction mixture by running the reaction mixture through anion exchange columns
and the radioactivity of samples and standards determined using a Beckman LS3801
liquid scintillation counter.
Total body camitine was estimated by determining camitine in liquid carcass
homogenates, and adding to that amount the amount of carnitine removed with
organs and tissues. Organ and tissue camitine was determined by multiplying the
camitine concentration by the weight of the tissue. This method probably resulted in
a small underestimate of total body camitine since the large intestine, stomach, and
caecum were removed but not assayed for camitine.

Creatinine and Renal Function:

Creatinine assays in urine were performed by the Jaffe reaction according to the
methods of Taussky ( 1954) as modified by Henry ( 1 967). Plasma creatinine was
determined using another modification of the Jaffe reaction by Raffael (1 976).
Creatinine clearance was calculated from plasma concentration and 24h urinary
excretion of creatinine, using the equation: Clearance = (UxfPx)V where
Ux = 24 h urinary creatinine excretion, Px = plasma creatinine concentration, and V =
urine flow in ml per minute. Camitine clearance was calculated by the same equation
except Ux and Px = are 24 h urinary carnitine excretion and plasma camitine
concentration, respectively.

47

Fractional tubular reabsorption (FTR) of camitine was calculated by the formula
(Zamora et al. 1995):

Ucne x Pcreat x
FTR% = { l _
} 1 00
Pcne Ucreat

Where FTR = fractional tubular reabsorption, Ucne = 24 h urinary excretion of
camitine (µmol/d), Pcne = plasma concentration of carnitine (µmol/L), Pcreat =
plasma concentration of creatinine (µmol/L), and Ucreat = 24 h urinary excretion of
creatinine (µmol/d).

Proximate analysis of Guinea Pig Carcasses
Guinea pig carcasses were thawed and shaven to remove hair. Large intestines,
stomach, and caecum were removed. The carcasses were homogenized in a blender
and the homogenate lyophilized for moisture determination. Aliquots of the dried
homogenate were assayed for protein by the kjeldahl method (Official Methods of
Analysis 1 984). Percent fat was determined by soxhlet extraction for 12 h using
hexane as the solvent. The percent fat in the sample was determined both by the
amount of the fat recovered in the flask, and by the loss of weight from the sample,
after extraction. The values obtained from the two methods were averaged for the
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reported fat percent. Mineral ash percent was determined by ashing an aliquot of the
lyophilized sample in a muffle furnace at 650° C.

Statistics

All values are expressed as group means ± SEM. Urinary camitine excretion was
expressed as µmol carnitine excreted per mmol creatinine. Significance of differences
were determined using analysis of variance (ANOVA) and Tukey' s test. Statmost for
Windows version 2.01 (DataMost Corp., Salt Lake City, UT) was used for ANOVA.
For uniary excretion of camitine differences were evaluated using a repeated
measures ANOVA using the l\fiXED procedure of SAS (Cary, N.C.). When the F
test indicated differences between groups, the differences were separated using
Fisher's protected least significant difference test. For regression analysis the
regression curve was generated using Excel for Windows version 5. 0 and regression
analysis performed using SAS (Cary, NC).
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Results

The difference in the ages of the two sets of guinea pigs introduced enough
variation in body weights, food consumption, and weight gain so that these data from
the two sets could not be meaningfully combined for analysis. There were no
significant differences among the dietary groups in initial and body weight, weight
gain, feed consumption, or feed efficiency in either set of animals (Table 4-4).
Urinary excretion of carnitine was significantly lower in all three groups of
choline supplemented guinea pigs than in the nonsupplemented group on day 5 and
for the remainder of the study (Table 4-5). There was a time dependent increase in
urinary carnitine excretion in the nonsupplemented group, that was not seen in the
supplemented groups. There was no apparent dose effect during that period since the
different levels of choline supplementation did not result in significantly different
urinary excretions of carnitine. On day 2, the excretion of the carnitine in the animals
supplemented with 5 and 1 0 g choline per kg diet was approximately half that of the
unsupplemented animals, although this difference was not statistically significant.
Carnitine concentration was determined in plasma, kidney, brain, liver, heart, and
skeletal muscle (Table 4-6). Plasma, brain, and liver concentrations of carnitine were
not significantly different between any of the groups. Kidney free carnitine was higher
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Table 4-4
Feed Consumption, Weight Gain, and Feed Efficiency in
Choline Supplemented and Non-Supplemented Guinea Pigs 1
Level of Choline
Supplement (g/kg diet)

0

2

5

IO

888.0
9 14.0
26.0
838.5
0.0339

914.5
9 14.5
0.0
939.0
0.0002

895.5
9 14.5
19.0
856.0
0.0248

First Set of Guinea Pigs
Beginning Weight
Final Weight
Weight Gain
Feed Eaten
Feed Efficiency

926.0
930.5
4.5
938.0
0.0068

Second Set of Guinea Pigs
298.3 ± 1 7.0
302.7 ± 3.8
3 14.3 ± 1 1 .6
Beginning Weight 300.7 ± 20.5
405.3 ± 1 5.3
402.7 ± 35.4
43 1 .7 ± 9.6
42 1.7 ± 9.7
Final Weight
107.0 ± 4.2
102.0 ± 17.0
1 1 9.0 ± 9.0
1 17.3 ± 14.4
Weight Gain
500.0 ± 24.9
573.7 ± 39.3
556.3 ± 25.3
5 13.0 ± 3 1 . 5
Feed Eaten
0. 1 962 ± 0.02 1 0.2 134 ± 0.007 0.203 1 ± 0.0 1 1 0.2 148 ± 0.0 1 1
Feed Efficiency

1

Values are group means (± SEM for the second set of guinea pigs) (n = 2 for the first
set and n = 3 for the second set). Differences between groups were evaluated by
ANOVA test but differences were not significant (P < 0.05).
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Table 4-5
Urinary Excretion of Carnitine in Guinea Pigs Supplemented
With Varied Levels of Choline for 21 Days 1
Level of Choline
Supplement
NEC
(g/kg diet)
0
2
5
10

Camitine (µmol/mmol Creatinine)
ASAC

AIAC

TOTAL2

0.1·
0.4·
0.4·
0.6·ti

23.2·
22.8
3 1 .4
34_3 •

0.9·
o.8·
0.3·
o.3 •t

45_5t
42.7
22.0
30 . 4 •t

0.4·

48 . 3 a,t
24.2b
15.4b
12 . 3 b,t

Day O of Study
14.o·
12.6
19.9
21.9·

8.5
9.8
11.0
11.8
Day 2 of Study

0
2
5
10

32.2a,t
27 . 4ab
11.4b
14.6b,•t

12. 5
14.7
10.4
15.5
Day 5 of Study

0
2
5
10

31.4a, t

16.5
9.8

7.6bc
5.9c.t

0.3·

7.6
5.8

0.2·
0.2·

1 4 . 1 ab

Continued
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Table 4-5 Continued

Level of Choline
Supplement
NEC
(g/kg diet)
0
2
5
10

Carnitine (µmolimmol Creatinine)
ASAC

AIAC

TOTAL

Day 14 of Study
52 . 7a, t
1 2 . 4b
20 . 4b
1 6.3 b, *t

3 . 2a

1 8.6
10.2
14.7
16. 5

,t

1 _ 5b,t
1 . 5b,t
1 . 2:

74 _ ga.t
24 . l b
37.7b
36 . 5 b,•

Day 2 1 of Study
0
2
5
10

40 . 5 a, tt
18 . 7b
18 . 4b
9 _ 9b,•t

Pooled
Standard Error 6.5

17.8
11 . 8
1 1 .4
7.8

2.8a.t
l . 3 b,t
1.6b,t
I .ob.ti

.,..., ·"'...,

0.3

6 1 . l a,ti

3 1 .7b
31.4 b
18.6b,•t
8.5

Values are means for the group, pooled standard error for carnitine fractions are
shown at the bottom of the table. Values in a column, for each day of the study, with
a different letter superscript (a,b,c) are significantly different from others in the same
column at the same time period (P < 0 . 05, n = 5) . Differences over time within
supplement groups, for each column, are indicated by different symbol superscripts
( * , t , t ), (P < 0.05, n = 5).
2
NEC = non-esterified carnitine, ASAC = acid-soluble acyl carnitine, AIAC = acid
insoluble acyl carnitine, Total = total camitine.
1
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Table 4-6
Plasma and Tissue Concentrations of Carnitine in Guinea Pigs
Supplemented With Varied Levels of Choline for 21 Days 1

Level of Choline
Supplement
NEC

ASAC

TOTAL

AIAC

Plasma (µmol/L)

(g/kg diet)
0
2
5
10

Carnitine

33.1 ± 6.0
40.4 ± 4.0
36.6 ± 8.3
1 5.6 ± 2.1

2.6 ± 1 .2
9.1 ± 3.4
8.9 ± 2.5
25.2 ± 7.3

2.2 ±
2.9 ±
1 .3 ±
2.0 ±

0.7
0.6
0.5
0.6

37.9 ± 6.6
52.3 ± 4.5
46.8 ± 11.2
42.8 ± 6.3

Brain (nmol/g)
0
2
5
10

131.7 ± 24.2
21 1.3 ± 54.5
154.1 ± 9.7
208.1 ± 51 .4

31.0 ± 1 45.0
39.3 ± 16.4
26.5 ± 6.6
26.0 ± 9.9

43.1 ± 7.6
41 .2 ± 4.8
34.5 ± 2.7
46.2 ± 9.9

205.8 ± 44.3
291.8 ± 70.0
21 5.1 ± 1 2.1
280.3 ± 63.7

Liver (nmol/g)
0
2
5
10

326.3 ± 48.9
341 .0 ± 34.4
359.0 ± 32.9
357.0 ± 43.4

5.3 ± 5.3
1 2.8 ± 5.3
21.8 ± 1 0.3
1 7.9 ± 1 0.6

Continued
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1 2.5 ± 1 .1
1 1 .3 ± 2.5
8.6 ± 2.0
1 3.2 ± 3.8

344.1 ± 50.5
365.1 ± 38.9
389.4 ± 42.8
388.2 ± 62.6

Table 4-6 - Continued

Level of Choline
Supplement

Camitine

NEC

ASAC

(g/kg diet)
0
2
5
10

AIAC

TOTAL

Kidney (nmol/g)
379.8 + 19.5a
397.1 1 8.4ab
391 . 5 24.3 ab
428. 1 1 9.3 b

+
+

±

55.6 ± 13.9
59.6 ± 7.0
68.6 ± 22.4
39.0 ± 6.5

1 5.4 +
1 7.3
21 .0
1 8.7

+
+

±

2.5 a
0.9ab
I .S b
I . l ab

450.8 ± 1 8.6
474.0 ± 1 9.0
481 .1 ± 21 .2
485.7 ± 21 .6

Heart (nmol/g)
0
2
5
10

1 042.5 + 1 45.9a
1311.2 I 08.2ab
1373. 0 1 4 I .8bc
1 063.0 ± 90. 5a

+

±

479.6 ± 33.1
505.5 ± 67.1
479.6 ± 61 .2
395.4 ± 72.0

23.2 ± 12.7a
50.8 ± 8.3 ab
b
88.4 +
- 7.9
87.2 ± 29.8b

1 545.2 + 1 40.7•
1 867.4 1 30.5b
1 941 .0 1 5 3. 1 b
1 545.6 ± 28.2·

+

±

Skeletal Muscle (nmol/g)
0
2
5
10

544.9 ± 25.0
635.0 ± 39.7
608.9 ± 56.9
624.1 ± 1 1 8.6

48.7 ± 1 4.7a
96.2 ± 33.4a
1 03.0 + 16.1 a
1 9 1 .2 ± 29.9b

21 7.3 ± 27.9
251 . 8 ± 42.4
230. 1 ± 1 8.6
23 1 .0 ± 64.7

81 0.9 + 27.6a
983 .0 51 .6b
942.2 65.5 ab
1 046.3-± 11 7.3 b

+
+

Tissue concentrations are nmol/g wet tissue. Values are expressed as means for the
group (n=5) ± SEM. Values in a column with a different superscript are significantly
different (P < 0.05) by ANOVA and Tukey's test.
2
NEC = non-esterified camitine, ASAC = acid-soluble acyl camitine, AIAC = acid
insoluble acyl camitine, Total = total carnitine.
1
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in the group supplemented with 1 0 g choline per kg diet, but there was no significant
trend in the other fractions or in total camitine. In the heart muscle, the AIAC was
elevated in all choli�e supplemented animals. In the groups supplemented with 2 and
1 0 g choline per kg diet, both free and total camitine were significantly higher than in
the nonsupplemented animals. There were no differences in heart ASAC between
groups. Heart camitine concentrations were not different for any fractions except
AIAC or for total camitine in the group supplemented with 1 0 g choline per kg diet.
All choline supplemented groups of guinea pigs had higher total camitine
concentrations in skeletal muscle. Although there appeared to be a dose dependent
increase in ASAC in muscle of choline supplemented animals, differences were
significant only in the I O g choline per kg diet group. Camitine concentrations in small
intestinal tissue are shown in Figure 4-1 . In all segments and in the whole intestine,
there was an apparent dose dependent increase in total carnitine concentrations in
choline supplemented animals, but was significant only in the group getting I O g
choline per kg diet. Differences in free or acyl camitines were not significant between
groups. Although the differences were not significant, there was an apparent increase
in both free and acyl camitines that, when combined, resulted in a significantly higher
total carnitine. The carnitine concentration of the lumen contents of the small intestine
and feces were highly variable, and there were no differences among groups {Table 47). Body composition, especially % fat, was affected more by age than by the choline
supplement {Table 4-8). Older animals had a much higher % body fat than did the
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Figure 4-1: Camitine concentrations in proximal (A), middle (B), distal (C), or
average of all segments (D) of the small intestine of guinea pigs given varied levels or
no supplemental choline added to ground diet for 21 days. NEC = non-esterified
camitine, ASAC = acid-soluble acyl carnitine, AIAC = acid insoluble acyl camitine,
and Total = total camitine. All values are the group mean (n = 5) ± SEM. Significant
difference (P < 0.05) from the control group (0 g/kg diet) by ANOVA Tukey's test
is indicated by an asterisk.
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Table 4-7
Intestinal Lumen Content and Feces Concentrations of Carnitine in Guinea
Pigs Supplemented With Varied Levels of Choline for 21 Days 1

Level of Choline
Supplement

Carnitine

NEC
(g/kg diet)
0
2
5
10

ASAC

TOTAL

AIAC

Small Intestine Lumen Content (nmoVanimal)
93 .96 ± 60.86
41.50 ± 7.66
58.61 ± 21. 8
65.73 ± 16.80

49.59 ± 0.55
39.21 ± 12.23
55.77 ± 1. 37
60.66 ± 10.02

20.66 ± 10.09
15.32 ± 3.60
23.25 ± 11.29
13.30 ± 3.69

164.22 ± 87.98
96.03 ± 20.73
134.42 ± 44.39
139.69 ± 5.24

1.51 ± 0.95
1.05 ± 0.03
0.45 ± 0.19
0.53 ± 0.19

7.61 ± 2.64
8.21 ± 1.59
6.80 ± 1.88
4.37 ± 0.66

Feces (nmoVg)
0
2
5
10

5.47 ± 15.4
6.14 ± 1.36
4.31 ± 1.15
3 .30 ± 0. 69

0.80 ± 0.45
1.02 ± 0.55
1.51 ± 0.79
0.53 ± 0.17

Values are expressed as means for the group (n=5) ± SEM. None of the means
between groups are significantly different (P < 0.05) by ANOVA.
2
NEC = non-esterified carnitine, ASAC = acid-soluble acyl carnitine, AIAC = acid
. insoluble acyl carnitine, Total = total carnitine.
1
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Table 4-8
Body Composition of Guinea Pigs Supplemented with
Varied Levels of Choline for 21 Days 1

Level of Choline Supplement (g/kg diet)
0

2

10

5

Both Sets of Guinea Pigs Combined (n = 5)
Moisture %
Fat %
Protein %
Ash %

60.8 ± 2.8
16.2 ± 3.5
1 5.4 ± 0.9
4.3 ± 0.3

62. 4 ± 3.4
15.3 ± 3.6
16.1 ± 0. 7
4.0 ± 0.2

60.5 ± 3.2
1 5.6 ± 3.1
16.5 ± 0. 9
4.6 ± 0.2

63.4 ± 3.7
1 4.2 ± 3.9
16. 1 ± 0.7
4.7 ± 0.3

Total %
Ratio %Fat / %Protein

96.8 ± 0.8
1.05 ± 0.23

97. 8 ± 1 .0
0.97 ± 0.25

97.1 ± 1.0
1.00 ± 0.25

98.4 ± 0.9
0.91 ± 0.27

First Set of Guinea Pigs (n = 2)
Fat %
Protein %
Ratio %Fat I %Protein

24. 3
1 5.3
1 .59

24.0
16.0
1 .53

23.2
1 4.6
1.63

23.5
1 5.1
1 .56

Second Set of Guinea Pigs (n = 3)
Fat %
Protein %
Ratio %Fat I %Protein

1 0.8 ± I. I
9.6 ± I . I
1 0.6 ± 1 .1
8.1 ± 1.1
1 7.7 + 1.0
16.8 + 1.1
15.4 ± 1.0
16.2 + 1 .0
0.69 ± d.02a 0.59± 0.08ab 0.60± 0.05ab 0.48-± 0.07b

Proximate analysis was performed on whole body homogenates of guinea pig fed 4
levels of supplemental choline in ground commercial diet. Total % is the combined
percentages of moisture, fat, protein, and ash for each group. Each value represents
the mean for the group (± SEM, n = 5 for the combined data, and second set of guinea
pigs). Different superscripts indicate significant differences by ANOVA and Tukey's
test (P < 0.05).
1
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younger animals. The % protein in the carcasses was similar between the two sets of
animals, but the younger animals had a higher % of moisture than the older animals
(66% vs 54%). Comparing the body composition data by ANOVA and Tukey's test
revealed no significant differences between groups in any of the measurements of body
composition, when the two sets of animals were considered as a whole. When the two
sets were analyzed separately. The ratio of %fat / %protein was significantly lower in
the animals supplemented with 10 g choline per kg diet than in the nonsupplemented
animals in the second (younger) set of animals. However, ANOVA is problematic in
comparing these groups. When the two sets are compared separately, there is an n of 2
in one set and 3 in the other; normally too small to be adequate for ANOVA. When
the two sets are combined, the variation in fat % between the two sets is so large that
too much variation is introduced by the age effect to permit differences to be
significant for choline supplementation. Regression analysis (Figure 4-2) was also
used for the data from the second set of guinea pigs to determine if choline dose could
be responsible for an apparent effect on %fat and the ratio of %fat / %protein, which
was used as an indicator of fat/lean body mass. There was not a significant decrease in
%fat with increasing choline supplementation (R2 = 0.23, P = 0. 1). There was a
significant trend (R2 = 0.47, P = 0.01) for a decrease in the ratio of %fat/%protein
with increasing choline in the second set of animals, suggesting that the variation in
choline dosage was responsible for 4 7% of the variation in the ratio of fat/protein.
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Figure 4-2: Regression analysis of the effect of varied levels of choline
supplementation on % body fat (top) and the ratio of %fat / %protein (bottom) in
whole body homogenates of guinea pigs.
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Total body carnitine was estimated by assaying the carcass carnitine and adding
back the camitine from the tissues that were removed (Table 4-9). When expressed on
a per kg body weight basis the carnitine concentration was higher in the choline
supplemented animals, with the difference being significant in 2 of the 3 choline
supplemented groups. When expressed on µmol/animal basis the differences were not
significant, probably due to the large variation in animal size between the two sets.
Camitine excretion was estimated for the study period by averaging the daily
excretion and assuming that average to be typical for all days during the study.
Camitine conservation was then estimated for the study period by subtracting the
average amount excreted in the choline supplemented animals from that excreted by
the control animals. This was compared to the average increase in total body carnitine
for each choline supplemented group over the unsupplemented group (Table 4-9).
The increased total body camitine accounted for approximately I 00% of the carnitine
conserved in the animals supplemented with 2 and I O g choline per kg diet, and about
40% of the conserved carnitine in the group supplemented with 5 g per kg diet.
The d 2 1 urine and plasma collections were used to further describe the effects of
choline on renal handling of carnitine (Table 4-10) . Creatinine excretion and
clearance were not affected by choline supplementation. Carnitine clearance was
reduced in choline supplemented groups but only significantly in the 2 g choline/kg
diet group. Fractional tubular reabsorption was significantly increased in all of the
choline supplemented groups.
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Table 4-9
Total Body Camitine and Urinary Conservation of Carnitine
in Guinea Pigs Supplemented with Varied Levels of Choline for 21 Days 1

Level of Choline Supplement (g/kg diet)
0
2
5
10
Total Carnitine
372. 5 ± 39.5 a 494.5 ± 22.0b 403 .8 ± 20.9a 48 1 . 3 ± 23 . l b
Carcass (µmol/kg bw)
1 54.4 ± 27.9 220.7 ± 41 .9 1 79.9 ± 37.8 2 1 3 . 5 ± 58.0
Carcass (µmoVanimal)
S. Intestine (µmoVanimal) 1 .3 ± 0. 1
1 .4 ± 0.2
1. 7 ± 0.2
1 .9 ± 0.2
3 . 8 ± 0.7
2.6 ± 0.4
3. 5 ± 0.5
2.7 ± 0.3
Heart (µmoVanimal)
0.9 ± 0.2
1 .0 ± 0.2
0.8 ± 0. 1
0.7 ± 0.2
Brain (µmoVanimal)
7.2 ± 1 .3
8.4 ± 2.8
8.7 ± 2.4
Liver (µmoVanimal)
7. 8 ± 2.0
2.2 ± 0. 5
2.2 ± 0.4
2.2 ± 0.3
2.2 ± 0.4
Kidney (µmoVanimal)
1 .7 ± 0.2
2.0 1 ± 0.2
1 .7 ± 0.2
1 .4 ± 0. 1
Muscle (µmoVanimal)
Total Body Camitine
1 69.8 ± 29.7 238.8 ± 44.9 1 98.7 ± 4 1 .3 23 1 .3 ± 6 1 . 8
(µmoVanimal)
Estimated Carnitine Excretion During
the Study (µmoVanimal) 1 26.8 ± 28.8 62.6 ± 23 .0 55.4 ± 1 3 . 8 64. 7 ± 1 7. 1
Estimated Carnitine Consetvation
62. 1
7 1 .4
(µmoVanimal)
64.3
Average Increase in Total Body
6 1 .5
69.0
28.9
Camitine (µmoVanimal)
Total body camitine was determined by adding total carnitine in each tissue removed
to th� total carcass carnitine for each animal. Carnitine excretion during the study was
estimated by averaging the 24h excretions during the experimental period and
multiplying by 21 d. Camitine conservation was estimated by subtracting carnitine
excretion during the experimental period in choline supplemented animals from that of
unsupplemented animals. All values are the group mean ± SEM except for some
estimates, for which only the values are shown.
Different superscripts indicate significant differences by ANOVA and Tukey' s test
(P < 0.05, n = 5).
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Table 4-10
Effects of Varied Levels of Choline Supplementation on Renal Excretion
and Reabsorption of Camitine and Creatinine 1

0

Level of Choline Supplement (g/kg diet)
2

5

10

Creatinine Excretion
78 .4 ± 1 7.4 1 1 0.8 ± 22. 1 1 08.4 ± 25.6
1 1 0.4 ± 1 5.2
(µmoVd)
Creatinine Clearance
0. 1 1 ± 0.02 0.09 ± 0.04
0.08 ± 0.03
0.06 ± 0.02
(mL/minute)
Carnitine Clearance
a
0.005 ± 0. 002 0.00 1 ± 0.001 b 0. 003 ± O.OO l ab 0.003 ± 0. 002 ab
(mL/minute)
Fractional Tubular
92.14 ± 1.94a 97. 92 ± 0. 29b 97.3 ± 0.25b 98.16 ± 0.55b
Reabsorption (%)
Creatinine and camitine clearances were calculated using the equation: Clearance =
(UxfPx)V where U = urinary excretion of x, P = plasma concentration of x, x =
creatinine or camitine, and V = urine flow in ml per minute. Fractional tubular
reabsorption was calculated by the formula:
FTR(%) = {1 - (Ucne/Pcne) (Pcreat/Ucreat)} x 1 00
Where FTR = fractional tubular reabsorption, Ucne = urinary excretion of carnitine
µmoVd), Pcne = plasma concentration of carnitine (µmol/L), Pcreat = plasma
concentration of creatinine (µmol/L), and Ucreat = urinary excretion of creatinine
(µmoVd). All values are shown as the group mean ± SEM. Values with different
superscripts are significantly different by ANOVA and Tukey's test (P < 0.05, n = 5).
1
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Discussion

The first set of animals maintained their weight during the study, but did not gain
weight, because they had reached adult weight at the onset of the study. The second
set, on the other hand, gained 1 00-150 grams during the study. This resulted in a near
zero feed efficiency in the adult animals, which would be expected in animals that are
now growing. The feed efficiency the younger animals varied from a low of 0. 19 (g
body weight/g feed) in the nonsupplemented group to a high of 0.2 1 in the animals
supplemented with 1 0g choline per kg diet. Neither feed efficiency, beginning body
weight, or final body weight were significantly different among groups.

Urine and Plasma Carniti.nes

Carnitine excretion, in urine, was not significantly affected by choline after 2 days
of choline supplemented diet. The excretion in the groups supplemented with 5 and
10 g choline per kg diet was about half that of the nonsupplemented group, but the
carnitine excretion on day two in the group supplemented with 2 g choline per kg diet
was nearly identical to that of the control animals, suggesting a delayed response at
the lower dose. By day 5 of the study, there was a significantly lower camitine
excretion in all of the choline supplemented guinea pigs, a trend that continued for the
remainder of the study. Analysis of variance also revealed a significant increase over
time in the urinary excretion of total carnitine and the NEC and AIAC fractions. The
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time dependent increase in urinary carnitine excretion were prevented by choline
supplementation, and total carnitine excretion was significantly lower on day 5 than
day O in the highest supplemented group. In previous studies there was a significant
increase in plasma carnitine concentration in guinea pigs. In this study, plasma
camitine was not significantly higher in the choline supplemented groups. This may be
due to the difference in the statistical tests and number of animals. In the previous
studies (Daily and Sachan 1 995) there were only two groups with an n of 12 and
significance determined by a t-test. In this study there were four groups of 5 animals
each and significance was determined by ANOVA and Tukey's test (a more
conservative test than a t-test) (Table 4-6). When the plasma data is analyzed using
Student-Newman-Keuls test, the difference between the nonsupplemented and 2 g
choline/kg diet groups is significant.

Tissue and Intestinal Carnitine

Skeletal muscle carnitine concentrations were higher in choline supplemented
animals and was significant in the groups supplemented with 2 and 1 0 g choline per
kg diet. There was an apparent dose effect, with the highest carnitine concentration in
the muscle of the guinea pigs receiving the highest choline supplement. The higher
muscle camitine in choline supplemented animals is consistent with the previous
studies. The muscle camitine in the group supplemented with IO g choline per kg diet
was 1 29% of that in the nonsupplemented group. Muscle carnitine has been shown to
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increase 1 0% in humans supplemented with l g/day of camitine for 6 months (Arenas
et al 1 991),
There was no indication of an intestinal carnitine loss in choline supplemented
guinea pigs. It was postulated that if carnitine was being lost from the intestinal tissue,
and not reabsorbed, this would be apparent as a decreased tissue concentration.
Instead, there was a dose-dependent increase in carnitine concentration in small
intestine tissue. This suggested that intestinal tissue is affected by choline
supplementation, in a manner similar to muscle tissue. It was also postulated that if
camitine was being lost into the lumen, then lumen camitine content of the choline
supplemented animals would be higher. The reverse turned out to be true, the lumen
carnitine content was highest in the control animals, although none of the differences
were significant. The camitine content of feces were also not different. The results do
not support the hypothesis that carnitine was being lost from the intestine or that such
loss resulted in a compensatory decrease in urinary camitine excretion. On the
contrary, there was an accretion of camitine in the intestinal tissue of choline
supplemented animals.

Body Composition

The body composition data was complicated by the age difference in the two sets
of guinea pigs (Table 4-8). In the older animals, fat was approximately 24% of the
body mass, but in the younger animals only about 1 6%; and age had a much greater
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affect on body fat than did choline supplementation. Nevertheless, nonsupplemented
animals in both groups had a higher percentage of body fat and a higher fat/protein
ratio than did the choline supplemented animals, but this was only significant for those
supplemented with IO g choline/kg diet in the second set of younger animals. The
otherwise lack of significance is not surprising because of the high variation due to
age effect when both sets were combined, and the low numbers per group (n = 2 and
n = 3) when the sets were considered individually. A regression analysis (Figure 4-2),
however, indicated no difference in fat percentages with increasing choline
supplementation (P > 0.05), but a significant dose-dependent effect of choline in
reducing the ratio of fat/protein (P = 0. 0 I ) in the younger animals. There was no
effect of choline on body composition in the mature animals. While the evidence for
an effect of choline supplementation in reducing body fat is intriguing, it is not strong
enough at this point to make a final conclusion.
The total body carnitine was approximately 29% higher, on a per kg body weight
basis, in choline supplemented animals, confinning that the reduced carnitine
excretion represents a choline induced carnitine conservation {Table 4-9). The
estimates of conservation of urinary carnitine closely matched the increase in total
body carnitine.
Others have demonstrated that choline deficiency can cause a carnitine deficiency
(Tsai et al. 1974) with reduced liver, muscle, and whole body carnitine. It has also
been shown that carnitine deficiency resulting from choline deficiency impairs fatty
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acid oxidation (Corredor et al 1 967). The unique aspect of this line of research is that
choline supplementation, in choline sufficient humans and animals, increases tissue
concentration and total body stores of carnitine.

Renal Regulation of Carnitine

The mechanism of the choline-carnitine interaction is unknown. The two best
characterized aspects of this interaction are the decrease in carnitine excretion and
increase in tissue accumulation of carnitine in choline supplemented animals. The
decreased carnitine excretion is not a result of impaired kidney function since
creatinine excretion and clearance rates are not affected in choline supplemented
animals (Table 4- 1 0). Instead, the decreased urinary excretion of carnitine is a result
of an increased fractional tubular reabsorption of carnitine in the kidney. There is no
easy explanation for how choline causes an increase in tubular reabsorption of
camitine. Three possible mechanisms may account for the choline induced increase in
renal carnitine reabsorption. 1) Choline acts as a co-transport molecule that facilitates
the reabsorption of carnitine. 2) Choline reabsorption rate is increased and that a lack
of specificity allows carnitine, a structural analog of choline, to also be reabsorbed by
the same mechanism. 3) The renal carnitine transport protein may be upregulated
following choline supplementation, causing an increase in fractional tubular
reabsorption.
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The first possibility, that choline may act as a co-transport molecule seems
unlikely. Choline and carnitine appear to use different transport mechanisms, since
carnitine transport is a sodium linked process (Stadler et al. 1993) and choline is not
(Zeisel 1 981 ). Furthermore, in studies of carnitine transport in rat renal brush-border
membrane vesicles, choline has been shown to have no effect on carnitine transport at
physiological concentrations. At very high concentrations of choline ( 100 mmol/L),
carnitine transport was inhibited by more than 50% (Stieger et al. 1 995). There is,
therefore, little reason to suspect that a co-transport mechanism is responsible for the
increase in renal reabsorption of carnitine in choline supplemented humans or animals.
The second possibility, that choline supplementation might upregulate choline
reabsorptive mechanisms is counter to what would be expected in this situation.
Upregulation of choline reabsorption would be more likely in choline deficiency.
There is some evidence for cross-reactivity between the two molecules, however.
Carnitine-acetyltransferase also has weak choline acetyltransferase activity, but
choline-acetyltransferase is not cross reactive (Sastry & Janson 1 994). This type of
interaction is suspect because of the similar structure of choline and camitine, but no
evidence is available to support such a conclusion.
The third possibility, that the transport mechanism for carnitine is upregulated, is
the most plausible. Although not yet identified, there is strong evidence for the
existence of a carnitine transport protein. Berardi et al ( 1995) expressed rat kidney
mRNA in Xenopus laveris oocytes, which induced an increased sodium dependent
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carnitine transport in the oocytes. There is also a well characterized inheritable defect
in the juvenile visceral steatosis (jvs) mouse involving renal reabsorption of carnitine.
This condition is a autosomally inherited recessive defect that, in homozygotes,
results in a depletion of serum, liver, and muscle camitine (Hayakawa et al. 1 990,
Koizumi et al. 1988). Horiuch et al {1 994) demonstrated that the primary defect in the
jvs mouse is in the renal reabsorption system for carnitine. It has been shown that the
administration of large amounts of carnitine can correct the consequences of the
defect (Horiuchi et al. 1 992, Horta et al., 1 996, Uenka et al. 1 996). As of now, the
putative camitine transport protein has not been identified, antibodies to it have not
been produced, nor the gene cloned; therefore the study of its expression is not
possible. The possibility that choline may in some manner increase the expression of
this protein, however, in an attractive theory that awaits further study.

Conclusions

There was not a clear dose response in this study. For most measured

parameters there were no significant differences between the lowest and highest
supplemental doses. Only the intestinal tissue data and regression of %fat/%protein in
the carcasses were dose dependent. This study has demonstrated, therefore, that low
doses of choline, have a near maximal effect on carnitine conservation in guinea pigs.
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The optimal dose, with regard to specific tissues, is still not clear since the effect was
greatest in skeletal muscle at the higher dosages, but not in heart.
This study also suggests that the cause of the choline induced decrease in urinary
excretion of carnitine is, in part, related to an increase in· the renal fractional tubular
reabsorption of carnitine; and that there is not an intestinal loss of carnitine. Finally,
the lower %fat/%protein ratio in choline supplemented guinea pigs suggests a
metabolic consequence of the choline-carnitine interaction. Other functional
consequences of choline supplementation were investigated in the next study.
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Chapter 5
Metabolic Consequences of Choline-Carnitine
Interactions
Introduction

The decreased %fat/% protein ratio of the choline supplemented guinea pigs in
the dose response study in chapter 4 suggested that choline induced carnitine
accretion in tissues might have metabolic consequences. Carnitine supplementation
has been utilized in attempts to improve athletic performance in several studies ( see
Table 5-1). Two primary issues remain unresolved from these studies. I ) Does
carnitine supplementation increase muscle carnitine concentrations? 2) If muscle
carnitine is increased, is the capacity for the muscle to oxidize fatty acids also
increased?
Severe carnitine depletion unquestionably results in a decreased capacity for fatty
acid oxidation. Muscle fatigue and weakness is a classic symptom of carnitine
deficiency {:worthily 1 983, Anonymous 1 985). Valproic acid is a anticonvulsant drug
know to cause camitine deficiency (Isom 1984). The effect of valproic acid therapy,
with and without supplemental carnitine, on the oxidation of energy substrates
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Table 5-1
Review of Carnitine Supplementation and Exercise

Reference
(species)

Carnitine Dosage
g/d

Duration
days

Results

Arenas et al. ( 1991)
(humans)

1

1 80

Muscle carnitine
increased over placebo
treated controls

Vukovich et al. (1 994)
(humans)

9

14

No effect on muscle
carnitine or fat oxidation

Gorostiaga et al. ( 1 989)
(humans)

2

28

RQ decreased during
exercise in carnitine vs
placebo supplemented

Wyss et al. (1 989)
(humans)

3

25

RQ decreased during
exercise in carnitine vs
placebo supplemented

.,"'

7

No effect on RQ or on
work capacity.

l b prior
to exercise

Increased work capacity
but no effect on RQ

Decombaz et al ( 1 993 )
(humans)
Veechiet et al ( 1 990)
(humans)
Heinonen and Takala ( 1 994)
(rats)

2

Carnitine depleted to
48% of controls
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No effect on work
capacity or fat oxidation

has been studied in humans (Melegh 1 994). In this study 8 patients receiving valproic
acid therapy had an average resting non protein RQ of 0.93, indicating that
carbohydrate was the predominant energy source. With supplemental carnitine, the
resting RQ decreased to 0.85, a more typical RQ which indicates that fat and
carbohydrates are contributing about equally to energy demands.
There are conflicting studies on the effects of camitine supplementation on energy
substrate utilization in normal individuals. Vukovich et al ( 1 994) reported that
carnitine supplementation (9g/d) for 2 weeks had no effect on either exercise
capacity, respiratory exchange ratio (RER) during 1 h of submaximal exercise at 70%
V02max, or muscle carnitine concentrations. However, Arenas et al. ( 1 99 1 )
demonstrated very different effects of camitine supplementation in a 1 80 d placebo
controlled experiment. Exercise training (long-distance running) significantly
decreased the muscle concentration of camitine (28.0 - 26.3 µmol/g noncollagenous
protein) in subjects given a placebo, but subjects given I g/d of carnitine had a
significant increase in muscle carnitine (26.3 - 29.0 µmol/g noncollagenous protein)
while participating in the same exercise routine. A similar effect was seen in sprinters.
The different effects on muscle camitine between the two studies may be an indication
that supplementation with smaller doses ( I vs 9 g) over a long period of time ( 1 80 vs
7 d) is more effective than higher doses for a short time. Unfortunately, Arenas et al.
did not determine a functional effect by measuring RER, endurance, or other possible
indicators of changes in oxidative capacity. Other researchers have, however,
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reported an effect of carnitine supplementation on exercise capacity and RER, but did
not determine effects on muscle carnitine concentrations (Table 5-1).
One recent study (Heineken and Tackle 1 994) found no effect of "moderate"
carnitine depletion in young rats on exercise capacity. In this study, the control group
was fed a commercial pellet diet, while the carnitine devoid group was given a
carnitine free isocaloric liquid diet. The carnitine deficient animals were given free
access to their diet, and the control group paired with one of the camitine devoid
animals, and food adjusted so that each rat received the same amount of nutrients,
except camitine, in each pair. The muscle camitine concentration in the carnitine
devoid animals was 48% of that in the control animals. The lower muscle carnitine,
however, did not result in a reduced swimming time to exhaustion, or in a reduced
oxidation of 14C palmitate after an 8h fast. The authors concluded that moderate
carnitine depletion does not affect exercise capacity or fatty acid oxidation. However,
there were several problems with this study. First the camitine assay measured only
free and short-chain acyl carnitines. Long-chain acyl camitines were not determined.
If there was a higher percentage of long-chain acyl carnitine in the devoid group, then
the differences in muscle carnitine content would be correspondingly smaller. Second,
these were young growing rats (same age as the second set of guinea pigs in the dose
response study), if camitine sufficiency resulted in a comparatively lower fat/lean
body mass, as seen with choline supplemented guinea pigs, then buoyancy would be
affected and could have a significant impact on swimming time. That is, if the
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carnitine devoid rats had a higher % body fat, they would be more buoyant and
require less work to swim. There was no body composition analysis in this study,
although the carnitine deficient rats gained significantly less weight during the feeding
period. The results of this study are difficult to interpret, and the validity of the
author's conclusions is not possible to access without additional information.
We have demonstrated that choline supplementation increases muscle camitine
(Daily and Sachan 1 995) and carcass carnitine (Table 4-9) in normally fed guinea
pigs. However we have not clearly demonstrated a functional consequence for this
increase in muscle carnitine. The objective of this research, therefore, was to
determine if choline induced camitine accretion in muscle increases fatty acid
oxidative capacity and endurance in guinea pigs using indirect calorimetry under
normal, starvation, and exercise conditions.

Materials and Methods

The protocol for this research was approved by the Animals Care and Use
Committee of the Universty of Tennessee. Twenty male Hartley guinea pigs
( SASCO, Omaha, NE) were divided into 2 groups to be fed ground commercial diet
(Purina Guinea Pig Chow no. 5025, Purina Mills, Richmond, IN) with or without
supplemental choline (3g/kg diet from choline chloride). It was not possible, to study
more than two animals simultaneously, therefore, animals were ordered in pairs and
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continued through the study as pairs, so that there would not be differences in age
(Age = 9. 7 ± 1 .2 weeks for both groups), and minimal differences in body weight
between groups.· The animals that began as pairs for the starvation study were then
used in the exercise study. Animal diets, and weights are compared in Table 5-2.

Experimental Design - Fasting Study
This study was designed to monitor gas exchange in all animals over an 8h period
prior to beginning the experimental diets under fed and unfed conditions and again
after 2 weeks on the experimental diets. When animals were monitored in the unfed
state, food was provided at 800 hours and removed at 900 hours. At 900 hours, gas
measurements were begun and each animal was measured during each one hour
period for 8 hours. When measurements were made during fed conditions, the animals
had free access to food except when in the gas monitoring chamber. The following
schedule was followed for each pair of guinea pigs.
Week 1 - Animals monitored for gas exchange twice for 8h under fed conditions.
Urine was collected for 24 h following the gas measurements with
animals having free access to food.
Week 2 - Animals monitored once for 8h with food withheld for the entire time.
Urine was collected for 24 h following the gas measurements while
animals still unfed. Animals were, therefore, unfed for 8 h prior to
beginning the urine collection and 32 h at the end of the collection.
Week 2 - Foilowing unfed experiment, animals were placed on experimental diets.
Week 3 - Animals on experimental diets.
Week 4 - Animals on experimental diets
Week 5 - Animals monitored for 8h under fed conditions, as before.
Week 6 - Animals monitored for 8h under unfed conditions as before.
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Table 5-2
Choline Content of Guinea Pig Diets and Initial & Final Body Weights 1

Experimental Group
(Level of Choline Supplement)
0

3

0
1 . 85
1 . 85

3.0
1 . 85
4. 85

524.8 ± 1 3 .0
686. 1 ± 22.0

502.9 ± 1 5 .4
667.2 ± 23 . 1

972.6 ± 53 . 7
1 025 .3 ± 39.2

93 8 . 8 ± 25. 6
944.9 ± 28. 1

Diets
Choline Supplement (g/kg)
Endogenous Choline (g/kg)
Total Choline (g/kg)
Animal Weights - Starvation Study
Initial Body Weight
Final Body Weight
Animal Weights - Treadmill Study
Initial Body Weight
Final Body Weight
1

Diets were prepared by grinding commercial diet and adding either no supplement or
choline from choline chloride. Values are means for the group ± SEM for body
weights. The same diets were continued through the starvation study and the treadmill
study.
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Animals were fed each morning lh prior to beginning the experiment. On days
when food was withheld, animals were fed normally in the morning but food was
removed when each animal was placed in the metabolic chamber. During each I h
period, animals were placed in the sealed metabolic chamber for 20min and gases
collected in a gas collection bag (allowed to fill for lmin) after 1 0, 1 5, & 20min. The
02 and CO2 content of each gas collection was determined using an Ametek S-3A/1I
oxygen analyzer and Ametek CD-3A carbon dioxide analyzer, values for the 3
collections were averaged and the average used as the value for that I h period.
Fed-state measurements were made twice during pre-supplement period and
experimental diet period. There was only one day of unfed measurements for each
dietary period, because of the possibility that the animals might not fully recover from
being unfed more times. After each 8h gas measurement experiment, the guinea pigs
were placed in metabolic cages (not the metabolic chamber that was used for
calorimetry) for 24h urine collections. Either feeding or unfeeding, whichever was
used in the gas measurements, was continued for the 24h urine collection. Urine was
collected and frozen at -20°C for analysis of carnitine and urea nitrogen at a later

time.

Experimental Design - Treadmill Study
The treadmill study was designed to evaluate choline induced changes in RER,
V02 , and endurance during submaximal exercise. All animals were trained to run on
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treadmill prior to starting the experiments. The average age of the pairs of guinea pigs
was 8. 1

± months, and the average time on experimental diets was 5.5 ± 0.9 months.

Each pair was trained on the treadmill for the same length of time and at the same
intensity to insure that no differences in training effects between groups influenced the
outcome. Treadmill training sessions were kept to 10 minutes to minimize any
trainining effect, since the purpose of this study was to evaluate the effect of
supplemental choline and not training.
There were four time periods in the experimental protocol, early morning, late
morning, early afternoon, and late afternoon, approximately 0900, 1 1 00, 1300, 1500
hours respectively, depending on how long the preceding animals ran. Each animal
was rotated between time periods and performed 4 running bouts each (except 1
which refused to run after two bouts).
The treadmill was set at a 5% incline with a speed of l Sm/min. This incline and
speed was determined during trial runs to be equivalent to a "fast walk", and an
exercise work rate that could be tolerated for extended periods. Animals were placed
in the treadmill unit for 1 5min prior to commencement of running. Air flow through
the unit was set at 2.1 L/min. After l 5min the first gas collection was taken and
analyzed as in the starvation study, and the first collection designated time O.
Immediately following the first gas collection the treadmill was started, air flow
increased to 3. 8 L/min, and gas collected and analyzed at 5 min intervals until the end
of the experiment. Animals continued running for 2h or until they refused to run
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longer, preferring the electric shock to running further. All animals were given a
minimum of 3 days recovery between exercise experiments.
After completion of the treadmill studies the animals were allowed to remain on
their respective diets for a minimum of 2 weeks before being killed. Four animals at a
time were placed in metabolic cages with or without food as follows: 1
nosupplemented-fed, 1 nonsupplemented-unfed, 1 choline supplemented-fed, 1
choline supplemented-starved, and urine was collected for 24h. After the 24h urine
collection the animals were anesthetized with methoxyflurane, blood taken by cardiac
puncture, and the animals killed by decapitation. Heart, liver, brain, kidney, and
muscle were collected for carnitine assay and frozen at -80°C. Liver and muscle tissue
were also processed for the CPT assay which followed killing of the animals.

Gas Analysis
Gas analysis instruments determine the percentage of the measured gases in an air
sample. In this case 02 and CO2 are determined and N2 assumed to be the remainder,
a reasonable assumption (Bursztein et al. 1 989). 02 and CO2 are determined using
the following equations.
V02 = (VI X FI02 ) - (VE X FE02 )

Where: V02 = volume of oxygen utilized.
FI02 = Fraction of oxygen entering the chamber (0.2093 for room air).
FE02 = Fraction of oxygen exiting the chamber.
VE and VI = the air flow in and out of the chamber and are assumed to be
equal.
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VC02 = (VE X FEC02 ) - (VI X FIC02 )
Where: VC02 = volume of carbon dioxide produced.
FEC02 = fraction of carbon dioxide exiting the chamber.
FIC02 = fraction of carbon dioxide entering the chamber (0.0003 for room
air).
VE and VI = air flow in and out of the chamber and are assumed to be equal.
These equations, therefore, use the fraction of the gases entering and leaving the
chamber, to determine the change in gas concentration from room air. The decrease in
the fraction of 02 and the increase in the fraction of CO2 are both multiplied by the
air flow per minute through the chamber to give the volume of each gas utilized or
produced. There are two adjustments made to the basic equations above that are used
in actual practice.
First VE and VI are adjusted to their equivalents at standard temperature and
pressure (STPD) from the values obtained at ambient temperature (ATPS) using the
following equation for the conversion factor (Bursztein et al. 1989, Osborn et al.
1969):
BP - PAH2 0
7 3 7° C
X
KI = 2 3 +
273 + T° A BP - PH 2 0(3 7 ° C)

where:
KI = conversion factor for converting gas volume at ATPS to STPD
2 73 = the absolute temperature (in degrees Kelvin) at O ° C
BP = barometric pressure
T0 A = the ambient temperature at which the measurements were made (degrees C)
PAH2 0 = the pressure of water vapor at the ambient temperature
PH2 0 = the pressure of water vapor.
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There is an assumption in the basic equations that because N2 is not absorbed, it
remains constant in inspired and expired air. In actual practice there is usually a small
difference in the percentage ofN2 between the two, and this is the second adjustment
that is made to the basic equations. For the concentration of nitrogen to be the same
in both inspired and expired air, the volume of CO2 added to the expired gases must
be equal to the volume of 02 removed, in other words, there must be an RER of 1 .
This not usually the case. Therefore, the following equations are expanded versions of
the basic equation, and are used to adjust for this effect in calculating V02 and VC02.

vco2 = {FECO2

[l - FEC02 -FE02 J
0.7904

VO2 = AF x {F/02 -[FEO2

x

- F1co2 } X AF

I - FEC02 -FE02 ]}
0.7904

Where:
AF = air flow through the chamber
0.7904 = fraction ofN2 in room air
VC02 = volume of carbon dioxide produced.
FEC02 = fraction of carbon dioxide exiting the chamber.
FIC02 = fraction of carbon dioxide entering the chamber (0. 0003 for room air).
V02 = volume of oxygen utilized.
FI02 = Fraction of oxygen entering the chamber (0. 2093 for room air).
FE02 = Fraction of oxygen exiting the chamber.
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A step by step description of the indirect calorimetry measurements is available in
appendix 2.
Carnitine and Urea Nitrogen Assays
Camitine was assayed using the radioenzymatic assay described in the materials
and methods section of chapter 4 (Cederblad and Lindstedt 1 972, Sachan et al 1 984).
Urea nitrogen was determined in the urine samples using Sigma kit no. 640, a
spectrophotometric urease/Berthelot determination for serum, plasma, or urine. In
this assay urea is first hydrolyzed releasing ammonia. The ammonia reacts with
alkaline hypochlorite and phenol in the presence of sodium nitroprusside (a catalyst)
to form indophenol. The concentration of ammonia is directly proportional to the
absorbance of indophenol at 570 nm, and the concentration is calculated based on the
absorption ofa standard solution of urea (1 0.7 mmol/L or 30 mg/di).

Carnitine Palmitoyltransferase -1 Assay
CPT-1 was assayed in intact mitochondria from muscle and liver processed
immediately following removal from the animals. Mitochondria were prepared
according the method of Johnson and Lardy ( 1 967). The tissues were first minced by
cutting with scissors in cold 0.25 mol/L sucrose and then homogenized using a
Potter-Elvehjem homogenizer with a teflon pestle rotating at 125 rpm. For liver, 3
passes on the homogenizer was used for the homogenization, additional passes were
required for homogenization of muscle. The homogenate was then centrifuged at 600

85

x g for 1 0 minutes and the supernatant containing the mitochondria decanted into a
second set of centrifuge tubes. The mitochondria were then centrifuged at 1 2,000 x g
for 1 0 minutes, the pellet was then resuspended in 0.25 mol/L sucrose and centrifuged
again at 12,000 x g for 1 0 minutes. The pellet was resuspended as before, protein
determined by biuret assay and the mitochondrial suspension adjusted to 1 0mg
protein/ml.
The method of Bremer ( 1981) was used to estimate CPT-1 activity in muscle and
liver mitochondria. Each assay mixture contained in a total volume of 0.5 ml: 82
mol/L sucrose, 70 mol/L KCI, 1 mol/L EGTA, 70 mol/L imidazole, 1 µg antimycin A,
2 mg BSA, 0.5 mol/L L-carnitine (0.4 mCi/mmol ofL-[methyJ-3H] carnitine) and 40
µmol/L palmitoyl CoA. For determination of malonyl CoA inhibition, malonyl CoA
concentrations were 0, 1 0, 25, and 50 µmol/L. For determination of the apparent km
of palmitoyl CoA, concentrations were 10, 50, 1 00, and 200 µmol/L and for the
determination ofkm for carnitine, concentrations were 0. 1, 0.5, 1, and 2 mmol/L.
Inhibition data was plotted in a double reciprocal manner : 1/ %inhibition on the y
axis and I/concentration of malonyl CoA on the x axis. The reciprocal of the inhibitor
concentration that gives 1/2 of maximum inhibition ( 1 /150 ) is at the intersection of the
x axis and the reciprocal of the maximum inhibition (lllmax ) is at the intersection of
the y axis. The calculations were performed with the assistance of the Hyperbolic
Regression Analysis 1.01 software (J.S. Easterby, Liverpool, UK). More details for
the assay are available in the protocol in appendix 1 .
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Statistics
The urinary excretion of carnitine in fed and unfed states was analyzed using a
split plot, repeated measures ANOVA using the MIXED procedure of SAS (Cary,
N.C.). When the F test indicated differences between groups, the differences were
separated using Fisher' s protected least significant difference test. Tissue camitine
concentrations, urinary excretion and plasma concentrations of camitine, and CPT
activity were compared using ANOVA and Student-Newman-Keuls test when the
ANOVA indicated differences among groups. Running time between groups was
compared using Student' s t test.

Results

Fasting Study
There was no effect of choline supplementation on either RER or oxygen
consumption when animals were fed or when food was withheld over Sh. The Sh
starvation did affect RER in both groups with the RER decreasing over time from
about 0.95 to about 0.79 (Figures 5-1 & 5-2). There was an apparent effect of
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Figure 5-1: Pre-experimental diet respiratory exchange ratios and oxygen
consumption. These pre-experimental diet measurements compared animals that
would in be either choline supplemented or nonsupplemented groups after starting the
experimental diets. Values are means for the group ± SEM ( n =IO when food
withheld, n = 20 when fed).
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Figure 5-2: Post-experimental diet respiratory exchange ratios and oxygen
consumption. The animals were either choline supplemented (ChS) or non
supplemented (NS). Values are means for the group ± SEM. There were no
differences between NS and ChS groups but RER and oxygen consumption were
significantly lower after 4h & 6h respectively, when food was withheld as compared
to fed states, by ANOVA and Student-Newman-Keuls test (P s 0.05, n = 1 0 when
food withheld, n = 20 when fed).
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8

being unfed on oxygen consumption, with oxygen consumption decreasing more over
time when food was withheld.
There were no differences between groups in 24h urinary excretion of camitine
prior to starting the experimental diets. There was, however, an effect of starvation
with both groups excreting less NEC but more ASAC and AIAC. ASAC was
increased nearly IO fold and total carnitine excretion almost 3 fold as a result of
starvation (Table 5-3). There was no significant effect of choline supplementation on
urinary excretion in this study (Table 5-3). Urinary excretion of acyl and total
carnitines was increased during starvation in both groups. There were also no
significant differences in 24h nitrogen excretion, with 524 ± 53 and 471

± 20 mg

N/d/kg body weighted being excreted during the fasting state in the nonsupplemented
and choline supplemented animals respectively.

Treadmill Study

The nonsupplemented and choline supplemented guinea pigs were run on a
treadmill for either 2h or to exhaustion, whichever came first, to evaluate if the added
stress of exercise would reveal differences in energy substrate utilization or endurance
between the nonsupplemented and choline supplemented groups (Figure 5-3). The
RER was not different between the nonsupplemented and choline supplemented
groups.
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Table 5-3
Urinary Excretion of Camitine in Guinea Pigs With or Without Choline
Supplement in Fed and Unfed States 1

Carnitine (µmol/d)

Level of Choline
Supplement
and Feeding
State
NEC

ASAC

TOTAL2

Prior to Starting Experimental Diets

(g/kg diet)
0 - Fed
3 - Fed
O - Unfed
3 - Unfed

AIAC

4.5 ± 0.7a
4.6 + 0.7a
1 .5 0.3 b
1.6 0.3 b

±+

2.8 ± 0.7a
2.8 + 0.8a
20. 8 2.9b
18. 1 2.0b

±+

0.4 ± 0. l a
0.5 + O. l a
0.8 + 0.2b
1. 1 0.3 b

±

8.0± 1.oa
7.6 ± 1.4a
23.4 + 3. l b
20.6 2. l b

±

While on Experimental Diets
0 - Fed
3 - Fed
0 - Unfed
3 - Unfed

4.8 ± 0.7a
2.6 + 0.7a
1.6 0.2b
2.2 0.3 b

+

±

2.5 ± 0.5a
1.5 + 0.4a
2 1 .7 1.6b
19.5 I .Sb

+
±

0.4 ± 0.4a
0.4 + O. l a
1.5 0.5b
1 .3 0.4b

±+

7.6 ± 1. l a
4.5 + 1.oa
24.7 I.Sb
23.0 1.7b

±+

Non-supplemented animals were fed ground commercial guinea pig diet, choline
supplemented animals were fed the same diet with 3 g/kg added choline from choline
chloride. Food was withheld for 8h (for gas measurements) prior to placing the
animals in the metabolic cages when unfed for 24h urine collections. When fed, the
animals were given free access to food. Values are expressed as means ± SEM for
the group (n=8 when animals were starved and n = 16 when fed). Different
superscripts indicate significantly different means among groups (P < 0.05).
2
NEC = non-esterified carnitine, ASAC = acid-soluble acyl carnitine, AIAC = acid
insoluble acyl camitine, Total = total carnitine .
1
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Figure 5-3: Respiratory exchange ratio of choline supplemented (ChS) or non-supplemented (NS) guinea pigs running on a
treadmill at a speed of 1 5 m/min and an incline of 5%. The equation for. the slope of each regression line is shown. Also
shown is the average running time ± SEM, there was no significant difference in running time by Student ' s t test (P > 0.05).

Final Blood, Urine, and Tissue Collections
After the animals had completed the starvation and treadmill studies, they were
allowed to recuperate for two ':"eeks, but remained on their respective diets. After
recuperation, four animals (2 nonsupplemented and 2 choline supplemented) at a time
were placed in metabolic cages and urine collected while fed or unfed (1 from each
group for each treatment). After the 24h urine collection, blood and tissues were
collected.
Urinary excretion of acyl and total carnitines was higher in starved animals,
indicating increased oxication of fatty acids. There was no differences in plasma total
carnitine either between groups or as a result of starvation (Table 5-4). There was,
however, a shift from mostly NEC to nearly equal amounts of NEC and ASAC in the
plasma of starved animals. The excretion of carnitine was not different between the
choline supplemented and nonsupplemented guinea pigs either during starvation or
when fed (Table 5-4). Urinary excretion of acyl and total carnitine was significantly
higher during starvation for both groups.
Brain total carnitine was higher in the choline supplemented group, due primarily
to NEC, but was only significant in the unfed animals (Table 5-5). The unfed state
tended to decrease liver free carnitine, but only significantly so in the
nonsupplemented group. There was also a trend toward decreased carnitine in the
hearts of unfed animals, due primarily to a decrease in ASAC. In kidney carnitine was
higher in fae �S animals during the fed state, but not different during starvation.
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Table : 5-4
Final Plasma Concentrations and Urinary Excretions of Camitine in
Control or Choline Supplemented Guinea Pigs in Fed or Unfed States 1

Level of Choline
Supplement
and Feeding
State
1'r.E:C
(g/kg diet)
0 - Fed
3 - Fed
0 - Unfed
3 - Unfed

Carnitine
ASAC

AIAC

TOTAL2

Urinary Excretion (µmol/d)
4.8 ± 1 .01
2.7 ± 1 .1 4
3.4 ± 0.6
4.3 ± 0.92

2.1 ± 0.8a
1.5 + 0.4 a
13.8 + 2.6b
13.3 2.9b

±

0.4 ± O.l ab
0.2 + O.l a
0.6 O.l bc
0.7 ± 0.12c

±

7.2 ± 1 . 4a
4.4 ± 1 .3 a
1 7.9 ± 3.3 b
1 7.7 ± 2.6b

Plasma (µmol/L)
0 - Fed
3 - Fed
0 - Unfed
3 - Unfed

30.4 ± 3.5a
31.3 ± 4.0a
20.5 + 1 .3 b
20.7 2.4b

±

9.0 ± 2.2a
8.0 + 2.l a
1 7.2 + 1 .6b
1 6.7 2.5b

±

2.2 ± 0.3
2.0 ± 0.3
2.0 ± 0.2
1 .8 ± 0.2

41 .6 ± 3.9
41 .3 ± 5.1
39.7 ± 1.0
39.2 ± 4.7

Non-supplemented animals were fed commercial guinea pig diet, choline
supplemented animals were the same diet with 3 g/kg added choline from choline
chloride. Food was withheld from half of the animals (Unfed) in each dietary
treatment for 24h prior to killing them. The remainder were given free access to food
(Fed). All animals had completed the exercise study at least 2 weeks before being
killed. Values are expressed as means ± SEM for the group (n = 5 for all groups
except n = 4 for both fed groups for urine data and choline supplemented fed group
for plasma data). Means among groups with different superscripts are significantly
different (P < 0.05), by Student-Newman-Keuls test.
2
1'r.E:C = non-esterified carnitine, ASAC = acid-soluble acyl carnitine, AIAC = acid
insoluble acyl carnitine, Total = total carnitine.
1
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Table : 5-5
Tissue Concentrations of Camitine in Guinea Pigs Fed Diets
With or Without Supplemental Choline in Fed or Unfed States 1
Level of Choline
Carnitine (nmol/gram wet tissue)
Supplement
and Feeding ---------------------
State
TOTAL
AIAC
ASAC
NEC
(g/kg diet)
Brain
0 - Fed
3 - Fed
0 - Unfed
3 - Unfed

99.4 ± 22. 5 a
1 20.3 ± 43 . l a
7 1 . 1 + 2 1 .3 a
1 96.6 43.4b

16.3 + 5.3 b
30.4 14.8 bc
1 . 8 ± 0.8 a
3 1 . 1 ± 5 .4c

±

1 9. 8 ± 1 . 5
1 6.7 ± 5. 1
20.2 ± 3 .0
1 8.2 ± 4.4

1 35 . 5 + 27.6a
ab
1 67.4 56. l
a
93 . 1 + 24.4
245 .8 39.5 b

Liver
0 - Fed
3 - Fed
0 - Unfed
3 - Unfed

338.6 + 9 1 . l a
252.0 44. 6ab
b
1 86.6 1 7.4
1 96.6 43 .4ab

4.5 ± 2.6
1 .9 ± 1 . 9
7. 1 ± 4.9
1 3 .6 ± 6. 8

1 3. 3 ± 6.4a
3 1 .5 ± 2.0b
22.9 ± 6.8 ab
26.7 ± 3 .7b

356.4 ± 9 1 .6
285.4 ± 43 .9
2 1 6.6 ± 1 7.2
236.8 ± 47. 0

Heart
0 - Fed
3 -Fed
0 - Unfed
3 - Unfed

654.5 ± 90.4
744.6 ± 1 1 7.7
679.3 ± 1 54.9
593 . 8 ± 96.4

Kidney
0 - Fed
3 - Fed
0 - Unfed
3 - Unfed

4 1 1 .2 ± 30.3
4 1 1 . 1 ± 1 7.7
478.4 ± 54.3
457.8 ± 47. 1

±

+
+

±

±
±

839.6 + 84.6a
792.4 208.3 ab
600.3 1 06.7b
563 . 5 1 1 1 . 9b

1 34. 1 ± 5 5.2
1 58.9 ± 1 0 1 . 1
1 60.8 ± 1 5.6
1 67.2 ± 6 1 .6

1 628.2 + 3 5 .2a
1 695.9 259.9ab
1 440.3 1 39.8ab
1 324.8 76.7b

76. 8 ± 25.4a
28.6 ± 2 1 . 7•b
32.9 + 14.7a
1 6.2 8.5 b

22. 8 ± 9.2ab
14.o + 3 _ 5•
22.5 2.0b
24. 5 6.5•b

5 1 0.8 ± 1 1 .9b
453 .7 ± 1 8.2a
555.5 ± 47.8b
498.5 ± 45 . 8ab

+
+

±

±

Continued
95

±+

+
+

±

Table 5-5 - Continued
Level of Choline
Supplement
and Feeding
NEC
State

Carnitine (nmol/gram wet tissue)
ASAC

AIAC

TOTAL

(g/kg diet)
Skeletal Muscle
454.8 + 70.9ab
0 - Fed
632.3 1 1 7.8b
3 - Fed
0 - Unfed
377. 0 ± 56.2a
3 - Unfed
389.6 ± 91 .9•

±

223.0 ± 46.1
272.7 ± 69.4
208.4 ± 77.8
320.2 ± 85.9

54.7 ± 14.8a
57.9 + 1 0_5•
1 27.8 1 7.2b
1 29.3 ± 32.0b

±

732.5 ± 84.4
962.9 ± 163. 8
71 3.1 ± 79.6
839.1 ± 1 08.7

NEC = non-esterified camitine, ASAC = acid-soluble acyl carnitine, AIAC = acid
insoluble acyl carnitine, Total = total carnitine. Non-supplemented animals were fed
ground commercial guinea pig diet, choline supplemented animals were the same diet
with 3 g/kg added choline from choline chloride. Food was withheld from half of the
animals (Unfed) in each dietary treatment for 24h prior to killing them. The remainder
were given free access to food (Fed). All animals had completed the exercise study at
least 2 weeks prior to being killed. Values are expressed as means ± SEM for the
group (n=5 except for all groups except n=4 the choline supplemented fed group).
Means among groups with different superscripts are significantly different (P < 0.05),
by Student-Newman-Keuls test.
1
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There was a significant decrease in muscle NEC in both groups when starved. The
muscle carnitine was not significantly different between NS and ChS animals when
either fed or unfed.

Carnitine Palnutoyltransferase Studies

Starvation increased CPT activity in the nonsupplemented animals, but not in the
choline supplemented animals. Malonyl-CoA inhibition was determined in all samples
as an indication of how much of the activity was due to CPT-1 as opposed to CPT-11
(Figure 5-4). The average Imax for malonyl-CoA in the liver samples was 83%,
indicating that most of the activity was due to CPT-1 .

Discussion

There was one major findings in this study; there is not an increase in fatty acid
oxidation in choline supplemented guinea pigs, that could be revealed by a lower
RER. This finding may be the result of three factors. First, RER may not be the best
functio�al consequence to evaluate, although the role of carnitine in fatty acid
oxidation is the best characterized function of carnitine. Second, guinea pigs may not
a be good model for studying fatty acid oxidation. Third, there may be no functional
consequence of the choline induced increase in muscle carnitine concentrations.
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Figure 5-4: Activity of CPT (top) in liver of non-supplemented (NS) or choline
supplemented (ChS) guinea pigs fed or unfed for 24h. Values are means for the
groups ± SEM. Differences were evaluated by ANOVA and Student-Newman-Keuls
test (P s 0.05, n = 5), different letters above bars indicate significant difference.
Malonyl-CoA inhibition of liver CPT activity was evaluated using a double-reciprocal
plot of malonyl-CoA inhibition as, explained in the materials and methods section.
The curve shown here (bottom) is an example of I animal. Averages of Imax and I5o
± SEM are shown.
98

0 .5

RER as a Functional Consequence of Increased Tissue Carnitine

The failure of choline supplementation to effect the RER in guinea pigs, under any
conditions, seems contradictory to the body composition data presented in chapter 4.
Of course, previous studies on the effect of camitine on athletic performance have
been contradictory also (Table 5-1 ). There has been only one study that measured
both muscle camitine and RER under exercise conditions in camitine supplemented
people. That study found no effect of camitine supplementation on either muscle
camitine or RER while exercising (Vukovich et al. 1994). However, camitine
supplementation did increase the muscle camitine concentration in the study by
Arenas et al ( 1991) but neither RER during exercise nor any other functional effect of
camitine was measured in that study. Other studies have found that camitine does
reduce RER (Gorostiaga et al. 1989, Wyss et al 1989), and one study found that
work capacity was increased, without an effect on RER when camitine was given 1 h
prior to exercise (Veechiet et al 1990). If tissue carnitine does increase work
capacity, it seems logical to assume that it does so by increasing the capacity of the
cell to transport fatty acids into the mitochondrial matrix for oxidation. However,
carnitine availability for fatty acid transport may not be rate limiting. It must be
remembered that camitine functions to shuttle acyl moieties between cellular
coenzyme-A pools. Removal of short-chain acyl groups from acyl -CoA in the
mitochondrial matrix, thereby freeing Co-ASH, is an important function of carnitine
and carnitine acetyltransferase (Bieber et al. 1992, Broquist 1 994). The concentration
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of coenzyme-A in human skeletal muscle is = 1 0 nmol/g, whereas carnitine
concentration is in the range of 2000 - 5000 nmol/g (Brass and Hiatt 1 994). The
intracellular carnitine pools is believed to act as a sink to help maintain an optimal
free/acyl-CoA, which is important in the regulation of several important enzymes
involved in intermediary metabolism, including pyruvate dehydrogenase (Bieber et al,
1 992). It has been demonstrated that, during intense exercise, there is a shift to higher
concentrations of muscle acyl-carnitine at the expense of free camitine (Friolet, R.,
Hoppeler, H., and Krahenbuhl, S. 1 994). There is a simultaneous increase in total
coenzyme-A, and a significant increase in the ratio of acyl/free-CoA. The implications
of changes in free and acyl CoA are difficult to interpret from measurements of total
tissue concentrations. It is believed that during ketotic states, the intramitochondrial
acyl/free-CoA ratio increases whereas the cytosolic acyl/free-CoA ratio decreases
(Bremer, J. 1983, Siess et al, 1978). It is possible that the maintenance of free CoA
can become the limiting action of camitine during exercise, and that failure to do so
may impair both fat and carbohydrate oxidation (Bieber et al, 1 992, Sugden and
Holness 1 994).
Because this study evaluated the effect of choline on muscle camitine, any effect
that would affect neurmomuscular signaling might also affect running ability.
Camitine in skeletal muscle may also have a role, through an interaction with choline,
in the synthesis of acetylcholine. Acetylcholine is an important neurotransmitter in
both nervous tissue and at the neuromuscular junction. Carnitine and acetylcarnitine
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have been proposed to facilitate the production of acetylcholine in the brain, and
carnitine acetyltransferase activity is known to be reduced in Alzheimer's disease
(Kalaria, R.N. and Harik, S.H. 1 992). In cultured neuroblastoma cells, the
combination of choline and camitine has been demonstrated to synergistically increase
the production of acetylcholine (Wawrzenczyk et al 1994 ). Whether the combination
of choline and carnitine in muscle cells could synergistically increase acetylcholine
signaling at the neuromuscular junction has not yet been investigated, but this
possibility can not be ignored as a possible functional consequence of the choline
camitine interaction investigated here, and deserves further investigation.

Guinea Pigs as a Modelfor Fatty Acid Oxidation

How efficiently guinea pigs utilize fat as an energy substrate has not been well
documented. The CPT- 1 activity reported here for guinea pigs is only about 25-30%
of that reported for rat liver, using the same assay (Kashfi et al 1993). The lower
activity can not be due to contamination with CPT-Il, since such contamination
increases CPT activity under assay conditions. This is not surprising, since the
reported Km for carnitine in guinea pig liver CPT-1 is 3 1 1 µmol/L, as compared to
37µmol/L and 39µmol/L in rat liver and human fetal liver, respectively (McGarry et al.
1 983). Guinea pig liver CPT-1 is also more sensitive to malonyl-CoA inhibition than
rat liver (Iso = 1 .3 8 vs 2.7 µmol/L). The high Km for carnitine and the greater

101

sensitivity to malony-CoA both suggest that guinea pig may not be able to utilize fat
for energy as efficiently as rats and humans.
The animal model may be responsible for the lack of effect on RER in this study,
but it must be remembered that the studies in carnitine supplemented humans show
conflicting effects on RER (Table 5-1). This may be due to the fact that there were
very small differences in RER in the studies. For instance, 0.883 vs 0.904 was
significant in the study by Wyss et al. (1 990)). Nevertheless, repeating the exercise
study in human subjects would result in better control, since running time can be better
controlled in human subjects than in guinea pigs.

Tissue and plasma carnitine
Tissue carnitine concentrations tended not to be significantly different between
groups, although there was a trend toward lower concentrations in starved animals
which was sometimes significant. It may not be surprising that there was not a
significantly higher muscle carnitine concentration in the choline supplemented,
exercised animals since Arenas et al. ( 1 99 1) demonstrated that exercise depletes the
muscle of camitine in humans. In this study plasma concentrations were the same
between choline supplemented and nonsupplemented animals in contrast to higher
plasma camitine in previous choline supplemented animals. The lack of difference in
plasma camitine may again be due to an effect of exercise, which is similar to what
has been seen in human studies.
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Conclusions

The lack of effect of choline supplementation on RER suggests that any possible
functional consequences of the choline mediated increases in tissue camitine
concentrations are independent of changes in fatty acid oxidation. Vecchiet et al.
( 1 990) found that camitine supplementation increased work capacity without
increasing RER in humans, therefore suggesting a functional consequence of carnitine
that is not related to the capacity for fatty acid oxidation. There is, therefore, the
possibility of a functional consequence of the choline induced carnitine conservation
that has not yet been investigated.
When feed was withheld from the animal there was and increase fatty acid
oxidation in the guinea pigs as evidenced by the derease over 8 hours in RER and by
the increased 24 h urinary excretion of acyl-camitines. However, there was no effect
of choline supplementation.
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Appendix 1
Carnitine Palmitoyltransferase Assay
Isolation of Mitochondria
1 . Prepare mitochondrial isolation mixture (MIM) - 0.25 M sucrose with l mM
EGTA. To make I L dissolve 85.6g sucrose and 0.38 g EGTA in distilled water and
adjust pH to 7.2 by adding IM tris dropwise.
2. Remove liver from killed animal and place in a beaker with cold :MIM:, and chop
into small pieces.
3 . Swirl pieces of liver to suspend blood and small particles of connective tissue and
decant. Repeat washing with MIM until blood is removed (2-3 times).
4. Homogenize liver using 3 passes of a Potter-Elvehjem homongenizer rotating at
125 rpm. Transfer to I or 2 50-ml centrifuge tubes
5. Centrifuge at 600 x g for I O minutes.
6. Decant the supernatant containing the mitochondria into a second set of centrifuge
tubes. Discard the pellet.
7. Centrifuge at 12,000 x g for IO minutes.
8. Discard supernatant and resuspend the pellet in :MIM: using a teflon stirring rod to
loosen the pellet, then transferring to a small Potter-Elvehjem homongenizer and
resuspend gently by hand.
9. Recentrifuge at 1 2,000 x g for IO minuies.
IO. Discard the supernatant and resuspend the pellet, but bring to a total volume of
only 3-4 ml this time.
1 1 . Assay protein by the Biruet method and bring the mitochondrial suspension to
I 0mg protein/ml.
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CPT Assay

Reagents and Solutions
I. lmidazole buffer (800 mmol/L): Dissolve 13 .62 g imidazole in approximately 200
ml double-distilled water (DDW). Adjust pH to 7.12 at room temperature and
bring to final volume of 250 ml in a volumetric flask.
2. Stock BSA (20%): Dissolve 10 g of bovine serum albumin (BSA) in approximately
40 ml DDW and bring to a final volume of 50 ml in a volumetric flask.
3. Antimycin A: Dissolve 10 mg in 10 ml ethanol.
4. Palmitoyl CoA (l mmol/L): Dissolve 10.42 mg of palmitoyl-CoA in 10 ml DDW.
Note: check purity of palmitioyl CoA to be certain of adding correct amount.
5. L-carnitine (50 mmol/L): Dissolve 98.85 mg of L-carnitine-HCl in 10 ml DDW.
Note: check purity of camitine to be certain of adding correct amount.
6. [Methyl-3H]-L-carnitine: 250 µCi (1 mCi/ml) from Amersham.
7. Perchloric Acid (1 mol/L): Add 89.7 ml of 70% perchloric acid (PCA) to a half
filled with DDW 1 L volumetric flask and bring to volume with DDW.
8. Saturated ammonium sulfate: Dissolve 100 g ammonium sulfate in 100 ml DDW
and heat while stirring with a stir bar. Allow to cool and store in a bottle at room
temperature.
9. Sucrose (2 mol/L): Dissolve 68.46 g sucrose in 50 ml DDW and bring to volume
in a 100 ml volumetric flask.
10. Potassium Chloride (1 mol/L): Dissolve 7.64 g potassium chloride (KCl) in
approximately 50 ml DDW and bring to volume in a 100 ml volumetric flask.
11. EGTA (0.1 mol/L): Dissolve 3 .804 g EGTA in approximately 80 ml DDW, bring
to pH 7.0 with 0.1 mol/L KOH. Bring to volume in a 100 ml volumetric flask.
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1 2. Cocktail - I (250 ml)
Imidazole (800 mM) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . 87.5 ml
Sucrose (2M) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ... 4 1 .0 ml
EGTA (0. 1 M) . . . . . . . .. . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . 10.0 ml
Antimycin A ( I mg/ml) . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 . 0 ml
BSA (20%) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . 10.0 ml
KCI ( IM) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . 70.0ml
Adjust pH to 7.2 and bring to a volume 250 ml with distilled water.
1 3 . Cocktail - II
L - Camitine (50mM) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10.0 ml
[ methyl 3H] L-camitine, I mCi/ml . . . . . . . . . . . . . . . . . 0. 4 ml
Bring to a total volume of 50 ml with distilled water.
Assay Procedure
1 . Add to 16 x I 00 mm test tubes - all samples should be run in duplicate
25 µI Cocktail II
Palmitoyl CoA According to protocol
Other Ingredients e.g. malonyl CoA
Distilled Water
2. Add enzyme ( 1 50 µg liver mitochondria, 75 µg heart mitochondria)
3 . Incubate for 5 minutes @ 3 7°C in a shaking water bath.
4. Add 50 µl Cocktail II and incubate for 5 minutes. For this step the number of
samples must be small enough to complete all within time with 5- 10 second
intervals between samples.
5. Stop reaction by adding 4 ml of IN perchloric acid (PCA) and placing on ice.
6. Centrifuge for 1 0 minutes at 2000 rpm.
7. Decant and discard supernatant, add O. 4 ml IN PCA and sonicate to dissolve
pellet. Resuspend in 4 ml IN PCA.
8. Centrifuge 5 minutes at 2000 rpm.
9. Decant and discard supernatant, add 0.4 ml IN PCA, and sonicate.
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10. Add 1 . 6 ml distilled water, 0 . 1 ml saturated ammonium sulfate, & 1 . 6 ml of n
butanol, and vortex.
1 1 . Centrifuge for 1 0 minutes at 2000 rpm to separate aqueous and butanol phases.
12. Remove an aliquot (0.8 ml) of the upper (butanol) layer and transfer to a
scintillarion vial.
1 3 . Add 5 ml scintillation fluid, mix and count.

Example ofAssay Scheme - Running a Malonyl CoA Inhibition Curve
Reagent (µl) Blank

Row A

Row B

Row C

Row D

Water

325

300

275

295

299

Cock I

1 25

125

125

125

1 25

Palmitoyl CoA

0

25

25

25

25

Malonyl CoA

0

0

25

5

1

Mitochondria

25

25

25

25

25

Cocktail II

25

25

25

25

25
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Example of Tube Setup - 4 tissue sample labeled 1-4 in duplicate

B B

ID ID
IC IC
IB IB
I A IA

2D
2C
2B
2A

2D
2C
2B
2A

3D
3C
3B
3A

3D
3C
3B
3A

4D
4C
4B
4A

4D
4C
4B
4A

B = blank, letters following numbers indicate sample # with treatment from rows in
the treatment scheme above.
Begin pipetting on the left with blanks and pipette Cocktail II into the tubes (with
other ingredients already added) at 5 second intervals. When 5 minutes have lapsed
since beginning with blanks begin adding PCA to the blank and pipette through the
sequence at 5 second intervals.
Calculations
First calculate the specific activity of for camitine in cocktail II:
Have: 50mM carnitine or 50 µmol/mL :. have 50 nmol/µL
Determine activity by scintillation counting in disintegrations per minute (DPM).
Example: 200,000 DPM for IOµL of cocktail II (1/5 50mM camitine )
I OµL of cocktail II has 2uL of 50 mM carnitine or I 00 nmol carnitine =
200,000 DPM/1 00 nmol camitine or 2000 DPM/nmol of carnitine.

Calculate activity by the equation:
.
DPMsample - DPMblank
1
. .
x -} + 5mm+ mgprotem
Actzwty = {
SpecificActivity(DPM I nmol) 0.5
Activity is in nmol/minute/mg protein
1/0. 5 or 2 is a result of taking a 0.8 ml aliquot of the 1 . 6 ml butanol used for the
extraction. 25 µL of I Omg/ml mitochondrial potein = .250 for mg protein.
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Indirect Calorimetry - Methods
Metabolic Basis of Indirect Calorimetry

Because of the different oxidation states of fats, proteins, and carbohydrates; the
oxidation of these nutrients result in different levels of 02 utilization and CO2
production. The following discussion is based on information from the book Energy
Metabolism, Indirect Calorimetry, and Nutrition by Bursztein et al. ( 1 989).
The stoichiometric equations for glucose and tripalmitate demonstrate the basis
for indirect calorimetry for the determination of relative energy substrate use.

Glucose: C6 H12 06 + 6 02 -+ 6C02 + 6 H2 0 + Energy
( 1 80 g) + ( 1 34.5 L} -+ (1 34.5 L) + (108 g) + 28 1 2 kJ
Tripalmitate: Cs1 H9s 06 + 72.5 02 -+ 5 1 CO2 + 49 H2 0 + Energy
(807 g) + ( 1 625 L) -+ (1 143 L) + (883 g) + 32,036 kJ
The respiratory quotient (RQ) of a person or animal can be used as an indicator of
relative amounts of fat and carbohydrate oxidation. The RQ is obtained by dividing
the CO2 produced by the amount of 02 utilized. Therefore, from the above equations
the RQ for glucose and tripalmitate can be calculated as follows.

Glucose: 1 34.5L CO2 + 1 34.5L 02 = 1 .0
Tripalmitate: 1 1 43. 5L CO2 + 1 625L 02 = 0.703
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Based on the RQ of expired gases, the relative amounts of fat vs carbohydrate can
be estimated. Protein, however, contributes about 1 5% of energy needs during
resting conditions (less during exercise) and has an RQ of about O. 8 1 . Because of its
midrange of RQ and small contribution to energy, protein is frequently ignored and
RQ expressed as a "non-protein" R.
The term RQ for measurements in indirect calorimetry is commonly used in the
literature, but it is technically incorrect. Oxidation of energy substrates occurs at the
cellular level and RQ is the ratio of CO2 produced and 02 used at the cellular level,
whereas the gases measured are those exchanged in the lungs. Gas exchange in the
lungs is a good indicator of RQ only if body stores of 02 and CO2 do not change.
What is actually measured is the respiratory exchange ratio (RER). Several factors
can introduce differences between RQ and RER including:

1 . Hyperventilation can result in excessive loss of CO2 and a high RER (Fox et
al. 1 988).
2. Oxidation of fats result in a low RER, on the other had, excessive
lipogenesis can result in a high RER, even when some fat is being oxidized,
this is sometimes seen in patients receiving high carbohydrate TPN formulas
(Bursztein et al. 1 989).
3 . Ketogenesis is a situation in which an 02 poor substrate (fat) is converted into
02 rich substrates (ketone bodies), which can result in a low RER. If the
ketones are rapidly oxidized they have little effect on RER, but if levels
become high enough that they are excreted into the urine, then RER may drop
below 0.07 (Bursztein et al. 1 989).
4. Gluconeogenesis, like ketogenesis is a process that converts 02 poor
substrates into 02 rich substrates and thereby utilizing oxygen, increasing
apparent 02 utilization and lowering RER (Bursztein et al 1 989).
1 27

Only rarely does the RQ or RER exceed 1 .0 or drop below 0.7. The highest RER
ever recorded was 1 .4 which was in an over-fed goose. During periods of starvation
the combination of gulconeogenesis and ketogenesis can cause RER to drop to about
0.68. It is rare, however, for RER to be outside the range of 0.7 - 1 .0. It is usually
assumed that at 0. 7 the subject is relying almost entirely on fat for energy, at 1 .0
almost entirely on carbohydrate, and at 0.85 the two contribute equally to energy
needs (Bursztein et al. 1989).
Estimates of energy use are sometimes made from 02 utilization alone. This is
valid when the RER of subjects or groups being compared are similar, and results in
only a small error when dissimilar. As can be seen form the equations for glucose and
tripalmitate, glucose will yield 20. 9 1 kJ of energy per L 02 (28 1 2 kJ + 134.5 L 02 )
and tripalmitate 1 9.71 kJ of energy per L 02 (32,036 kJ + 1625 L 02 ). Comparing
energy yield from 02 utilization alone results in only about a 6% differ�nce between
1 00% fat and 1 00% carbohydrate oxidation.
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Gas Analysis - Equipment Setup
The gas analysis apparatus is setup as shown in Figure A-1 . The usual procedure is to
draw gasses through the 02 and CO2 sensors with the pump. The equipment used is:
1. Ametek N-22M - oxygen sensor.
2. Ametek S-3A/II - oxygen analyzer.
3. Ametek P-61B - carbon dioxide sensor.
4. Ametek CD-3A - carbon dioxide analyzer.
5. Ametek R-1 - flow control.
Caution must be observed to be certain that air lines are connected correctly.
When unreasonable measurements occur, the air lines should be checked to be
certain. The equipment must be set up so that adequate ventilation is available to the
instruments to prevent overheating. It is also important that the equipment be set up
in an area with adequate ventilation so that the ambient gas concentrations will remain
stable. Gas values from expired air are compared to ambient gas concentrations in the
room (normally 20.93% and 0.03% for 02 and CO2 respectively). If the inspired
room air changes from these values, erroneous values for gas utilization and
production will result. The pump must be set to control the flow rate of gasses
through the system. A flow rate of 50-300 ml/minute is acceptable, however I 00
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Figure A-1 : Equipment setup for gas analysis. Gasses are pulled trough the sensors by
the pump. Heavy lines indicate gas lines except where labeled as electronic cables.
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ml/minute is ideal for most applications. The flow rate is adjusted by turning the knob
below the flow meter on the pump. A reading on the flow meter of approximately
1 .25 mm corresponds to a flow rate of I 00 ml/minute. For determining reading for
other flow rates see Figure 11-4 on page 28 of the manual for the Ametek oxygen
analyzer.

Equipment Maintenance

Oxygen Analyzer
Approximately once a week the cell restore cycle should be activated. This is
accomplished by using a pencil or small screwdriver to push the button inside the hole
labeled "cell restore" on the front panel of the analyzer. This should only be done
when the unit is running and gas flowing through the unit. Normally the unit is left
running all the time, unless it is going to be unused for a long period of time. Gas lines
need to be checked periodically to be certain that there are no leaks and that each is
securely in place so that no contamination from outside air is getting into the system.
Caution must be observed to avoid allowing flammable gasses to pass through
the system. Too much of a flammable gas could damage the analyzer when passed
through the high temperature cell and ignited, small amounts would use oxygen for
combustion and result in low oxygen values.
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Carbon dioxide analyzer
As with

the oxygen analyzer, the air lines need to be regularly inspected. Once a

month the cells on the sensor need to be cleaned. To clean the cell first tum off the
unit and allow to cool. Then disconnect the air lines, both in and out, and flush warm
water with a detergent through the in and out ports - both directions. Then flush both
directions with distilled water followed by flushing with alcohol. Flow clean dry air
through the system, with the system still turned off, for at least one hour before using.
Note: I prefer to do both the cell restoration, and flushing operations on a Friday and
allow the unit to run over the weekend, before using it for an experiment on Monday.
These procedures are· the only routine maintenance for these instruments. For
other trouble-shooting ideas and procedures, refer to the manuals.

Startup and Calibration
Drying tubes
Drying tubes need to be prepared for drying gasses before entering the analyses
equipment. Tubes made from tygon tubing with connectors are prepared for this use.
Prior to use, tubing is cleaned by removing old desiccant and placing new glass wool
inside the connectors. One connector is placed on one side of the tygon tubing and
the tube filled with desiccant from the other side. After filling, a connector is used to
close the open end of the tubing. Air is blown through the newly filled drying tube to
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remove dust, so as to avoid contamination of the instruments. One tube can be used
for up to 4 hours.
Maintaining uniformly dry gasses is essential for accurate measurement of gasses,
especially oxygen. It is possible to adjust measurements based on relative humidity,
but drying gassed before measuring them is more convenient and the generally
accepted practice. For a diagram of the effect of humidity on oxygen measurements
see Figure II-3 on page 26 of the Ametek oxygen analyzer manual.

Oxygen Analyzer
1 . Tum on the power at least 30 minutes prior to operation, 2 hours if possible. When
using this instrument frequently, leave the power on all the time.
2. Set the dial to 02%.
3. Set the reference/unknown switch to the reference position. Allow room air to flow
through the system in the same manner as sample air will be. Set the cell zero
potentiometer to midrange.
4. Tum the reference/unknown switch to unknown position and adjust the reference
potentiometer until the display reads the correct 02% (20.93% for room air). A single
point calibration is adequate for the oxygen meter and room air is a good choice as a
calibration gas for indirect calorimetry. See page 22 of the Ametek oxygen analyzer
for more information on calibration gasses.
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Carbon dioxide analyzer
1 . Tum on power switch at the same time that the oxygen analyzer is turned on.
2. Flow room air through the system in the same manner that sample gas will be
analyzed.
3 . Adjust the zero potentiometer until the display reads 0.03% (the CO2% of room
air}, if using room air.
4. Flow a calibration gas with approximately 5% CO2 through the system, for which
the exact concentration is known, and adjust the span potentiometer until the display
reads the correct concentration.
Whenever flowing gasses through the system it is imperative that the gasses
not be forced through under pressure. This may result in a rupture of the cells
and expensive repairs! Gas from a tank may be sampled by placing a small tube
from the gas analyzer inside a much larger tube from the tank. The large tube must be
large enough to allow free escape of gas from around the small tube, thereby
preventing pressure from the tank from forcing gasses through the system. The
system can also be checked by burning methanol in an alcohol burner. Methanol bums
at an RQ of 0.67 and this can be used to determine if the system is working well. The
alcohol must be burned at a very low flame to avoid overheating the chamber and
possibly setting it on fire. Calibration gasses can also be purchased, these work well,
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but the alcohol burner can be placed in the cage and test the whole system as it will be
used with an animal.
Note: These instructions are basic reminders of routine procedures. Before using
the equipment for the first time, the manuals should be studied.

Gas Sampling

The most important consideration for gas sampling is that a thoroughly mixed,
representative sample be collected. The change in gas concentration from ambient air
to that exiting in the chamber housing the animal being studied, times the air flow rate
is the amount of oxygen utilized and carbon dioxide produced. The basic equations
are:
V02 = (VI X FI02 ) - (VE X FE02 )
Where: V02 = volume of oxygen utilized.
FI02 = Fraction of oxygen entering the chamber (0.2093 for room air).
FE02 = Fraction of oxygen exiting the chamber.
VE and VI = the air flow in and out of the chamber and are assumed to be
equal.
VC02 = (VE x FEC02 ) - (VI x FIC02 )
Where: VC02 = volume of carbon dioxide produced.
FEC02 = fraction of carbon dioxide exiting the chamber.
FIC02 = fraction of carbon dioxide entering the chamber (0.0003 for room
�.
VE and VI = air flow in and out of the chamber and are assumed to be equal.
See material and methods for more details on calculations.
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Both systems used in this dissertation research used fans to mix the gasses. This
prevents air currents forming in the chamber and sampling of gasses that are not
representative of the gas content of the chamber.

Air Flow Rates:

The concentration of gasses in the cage are affected by several factors, including:
I) the size of the chamber, 2) the size of the animal, and 3) the flow rate of air
through the chamber. Greater changes in the gas concentrations have the advantage
of making small drifts in calibrations of less consequence. On the other hand, to great
CO2 and too low 02 concentrations will introduce metabolic effects that are not
intended. To avoid hypoxic conditions the CO2 concentration should not exceed 1%.
In general a air flow rate of 2-3 L/minute will give the desired results.
Setting up the dessicator chamber:
The plastic dessicator chamber is used to measure gasses in resting animal. An air
line is run from the oil free vacum/pressure pump to the air flow valve and then the
glass flow meter. From the glass flow meter the air line goes to the side tube on the
cage. The air line from the top of the cage takes the air out of the cage to a second
flow meter which monitors the air leaving the cage to insure that adequate air is
flowing through the chamber and that there are no major air leaks. A small loss of air
flow is not a problem, as long as there is a positive pressure of air so that air is not
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leaking into the chamber from the outside. The flow rate going into the chamber is
used for calculations and only a small percentage of the air coming out of the chamber
is used for analysis. The air coming from the second air flow meter is collected into a
gas collection bag for analysis.

Steps in using the dessicator chamber and treadmill:

1 . Place a new drying tube on the air line going to the gas analysis instruments.
2. Calibrate the instrument after allowing dry air to flow through the instruments for
at least 5 minutes.
3 . Check the gaskets on the end covers of the treadmill unit, or place gasket grease on
the surfaces of the dessicator unit.
4. Connect the hose from the flow meter attached to the air pump to the air inlet at
the top of the end plate behind the fan on the treadmill, or to the tube at the side of
the dessicator unit.
5. Place an animal in the treadmill chamber or dessicator unit and seal. Adjust the gas
flow rate - a lower flow rate is frequently used for the resting baseline than for
exercising animals.
6. Tum on the air pump and electrical shock coils on the treadmill, check the air flow
meters to make certain that adequate air is flowing through the chamber.
7. Allow gasses to equilibrate for 1 0 minutes before collecting gasses.
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8. Collect gas by inserting hose on gas collection bag into the hole at the bottom of
the end plate behind the fan of the treadmill from the line from the out air flow meter.
10. Tum on treadmill while measuring gasses from non-exercising baseline collection.
12. Close the gas bag and mix gasses in the bag by pressing and releasing the bag.
1 3 . Attach the bag to the drying tube leading to the analysis instruments.
14. Allow instrument readings to stabilize for 3 0 seconds and record the values.
1 5 . Remove the gas bag from the drying tube and allow the instruments to re-calibrate
to room air. Do not be too quick to adjust the instruments, the oxygen analyzer takes
a long time to recover to the baseline readings. The CO2 readings will change more
quickly than 02 since the gas passes through the CO2 sensor first.
16. Remove air from the gas collection bag by attaching it to the vacum side of a
vacum pump.
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